Cancer Research and Treatment

Original Articles

Weight Change after Cancer Diagnosis and Risk of Diabetes Mellitus: A Population-Based Nationwide Study: Hye Yeon Koo, Kyungdo Han, Mi Hee Cho, Wonyoung Jung, Jinhyung Jung, In Young Cho, Dong Wook Shin; Received June 25, 2024 Accepted August 28, 2024 Published online August 29, 2024; DOI: https://doi.org/10.4143/crt.2024.586 [Epub ahead of print]

Purpose
Cancer survivors are at increased risk of diabetes mellitus (DM). Additionally, the prevalence of obesity, which is also a risk factor for DM, is increasing in cancer survivors. We investigated the associations between weight change after cancer diagnosis and DM risk.
Materials and Methods
This retrospective cohort study used data from the Korean National Health Insurance Service. Participants who were newly diagnosed with cancer from 2010 to 2016 and received national health screening before and after diagnosis were included and followed until 2019. Weight change status after cancer diagnosis was categorized into four groups: sustained normal weight, obese to normal weight, normal weight to obese, or sustained obese. Cox proportional hazard analyses were performed to examine associations between weight change and DM.
Results
The study population comprised 264,250 cancer survivors. DM risk was highest in sustained obese (adjusted hazard ratios [aHR], 2.17; 95% confidence interval [CI], 2.08 to 2.26), followed by normal weight to obese (aHR, 1.66; 95% CI, 1.54 to 1.79), obese to normal weight (aHR, 1.29; 95% CI, 1.21 to 1.39), and then sustained normal weight group (reference). In subgroup analyses according to cancer type, most cancers showed the highest risks in sustained obese group.
Conclusion
Obesity at any time point was related to increased DM risk, presenting the highest risk in cancer survivors with sustained obesity. Survivors who changed from obese to normal weight had lower risk than survivors with sustained obesity. Survivors who changed from normal weight to obese showed increased risk compared to those who sustained normal weight. Our finding supports the significance of weight management among cancer survivors.

Citations

Citations to this article as recorded by

Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study
MI Hee Cho, Jinhyung Jung, Hye Yeon Koo, Wonyoung Jung, Kyungdo Han, In Young Cho, Dong Wook Shin
Diabetes & Metabolism.2025; 51(1): 101604. CrossRef

412 View
41 Download
1 Crossref

Lung and Thoracic cancer

Psychometric Validation of the Korean Version of the Cancer Survivors’ Unmet Needs (CaSUN) Scale among Korean Non–Small Cell Lung Cancer Survivors: Danbee Kang, Genehee Lee, Sooyeon Kim, Heesu Nam, Sunga Kong, Sungkeun Shim, Jae Kyung Lee, Wonyoung Jung, Sumin Shin, Hong Kwan Kim, Jae Ill Zo, Young Mog Shim, Dong Wook Shin, Juhee Cho; Cancer Res Treat. 2023;55(1):61-72. Published online February 23, 2022; DOI: https://doi.org/10.4143/crt.2021.1583

Abstract PDF PubReader ePub

Purpose
The purpose of the study was to validate the Korean version of Cancer Survivors’ Unmet Needs (CaSUN) scale among non–small cell lung cancer survivors.
Materials and Methods
Participants were recruited from outpatient clinics at the Samsung Medical Center in Seoul, South Korea, from January to October 2020. Participants completed a survey questionnaire that included the CaSUN. Exploratory and confirmatory factor analysis and Pearson’s correlations were used to evaluate the reliability and validity of the Korean version of the CaSUN (CaSUN-K). We also tested known-group validity using an independent t test or ANOVA.
Results
In total, 949 provided informed consent and all of which completed the questionnaire. Among the 949 patients, 529 (55.7%) were male; the mean age and median time since the end of active treatment (standard deviation) was 63.4±8.8 years and the median was 18 months. Although the factor loadings were different from those for the original scale, the Cronbach’s alpha coefficients of the six domains in the CaSUN-K ranged from 0.68 to 0.95, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the CaSUN-K were high. Moderate correlations demonstrated the convergent validity of CaSUN-K with the relevant questionnaire. More than 60% of the participants reported information-related unmet needs, and the CaSUN-K discriminated between the needs reported by the different subgroups that we analyzed.
Conclusion
The CaSUN-K is a reliable and valid measure for assessing the unmet needs in a cancer population, thus this tool help population to receive timely, targeted, and relevant care.

Citations

Citations to this article as recorded by

Supporting Life Adjustment in Patients With Lung Cancer Through a Comprehensive Care Program: Protocol for a Controlled Before-and-After Trial
Wonyoung Jung, Alice Ahn, Genehee Lee, Sunga Kong, Danbee Kang, Dongok Lee, Tae Eun Kim, Young Mog Shim, Hong Kwan Kim, Jongho Cho, Juhee Cho, Dong Wook Shin
JMIR Research Protocols.2024; 13: e54707. CrossRef
Validity and Reliability of a Simplified Chinese Version of Cancer Survivors' Unmet Needs Scale (CaSUN)
Xiaojingyuan Xu, Xiaoyun Liang, Shiquan Yin
Psycho-Oncology.2024;[Epub] CrossRef
Unmet Supportive Care Needs after Non-Small Cell Lung Cancer Resection at a Tertiary Hospital in Seoul, South Korea
Junhee Park, Wonyoung Jung, Genehee Lee, Danbee Kang, Young Mog Shim, Hong Kwan Kim, Ansuk Jeong, Juhee Cho, Dong Wook Shin
Healthcare.2023; 11(14): 2012. CrossRef
Kanserden Kurtulanların Karşılanmayan İhtiyaçları Ölçeğinin Türkçeye Uyarlanması: Geçerlik ve Güvenirlik Çalışması
Gülyeter Erdoğan Yüce, Gamze Muz, Ayser Döner
Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi.2023; 10(3): 264. CrossRef
Psychometric properties of the Slovenian version of the Cancer Survivors’ Unmet Needs (CaSUN-SL) measure in post-treatment cancer survivors
Špela Miroševič, Polona Selič-Zupančič, Judith Prins, Vesna Homar, Zalika Klemenc-Ketiš
BMC Psychology.2022;[Epub] CrossRef

5,978 View
169 Download
4 Web of Science
5 Crossref

Hematologic malignancy

Association between Kidney Function, Proteinuria and the Risk of Multiple Myeloma: A Population-Based Retrospective Cohort Study in South Korea: Taewoong Choi, Wooin Ahn, Dong Wook Shin, Kyungdo Han, Dahye Kim, Sohyun Chun; Cancer Res Treat. 2022;54(3):926-936. Published online September 27, 2021; DOI: https://doi.org/10.4143/crt.2021.951

Abstract PDF Supplementary Material PubReader ePub

Purpose
While renal impairment is one of the first clinical manifestations of multiple myeloma (MM), declined renal function may conversely be a risk factor for cancers including MM. In this study, we investigated the relationship between chronic kidney disease and MM at a population level.
Materials and Methods
A total of 9,809,376 adults who participated in a nationwide health screening program and had no MM, cancer or end-stage renal disease at baseline were investigated for incidence of MM. The impact of estimated glomerular filtration rate (eGFR) and random urine dipstick proteinuria, and interactive associations of the two factors on the MM incidence were evaluated.
Results
The general incidence of MM was 4.8 per 100,000 person-years (mean follow-up of 8.3 years). Participants with eGFR < 60 mL/min/1.73 m² (5.8% of participants) had higher MM incidence than those with eGFR ≥ 60 mL/min/1.73 m² (adjusted hazard ratio, 1.29; 95% confidence interval, 1.17 to 1.43). When eGFR was graded into five levels, there was a significant inverse dose-response relationship between eGFR level and MM incidence at the lower eGFR levels (reference: eGFR 60-89 mL/min/1.73 m²). A dose-response relationship was also found with degree of dipstick proteinuria and incidence of MM.
Conclusion
Adults with decreased renal function indicated either by decreased eGFR or presence of proteinuria are at a higher risk of developing MM compared to those without, and there is a dose-response relationship between the severity of renal impairment and MM incidence.

Citations

Citations to this article as recorded by

Quantitative risk factor analysis of prior disease condition and socioeconomic status with the multiple myeloma development: nationwide cohort study
Suein Choi, Eunjin Kim, Jinhee Jung, Sung-Soo Park, Chang-Ki Min, Seunghoon Han
Scientific Reports.2024;[Epub] CrossRef

7,285 View
144 Download
1 Web of Science
1 Crossref

Lung Cancer

Conditional Survival of Surgically Treated Patients with Lung Cancer: A Comprehensive Analyses of Overall, Recurrence-free, and Relative Survival: Dong Wook Shin, Jong Ho Cho, Jung Eun Yoo, Juhee Cho, Dong Woog Yoon, Genehee Lee, Sumin Shin, Hong Kwan Kim, Yong Soo Choi, Jhingook Kim, Jae Ill Zo, Young Mog Shim; Cancer Res Treat. 2021;53(4):1057-1071. Published online March 9, 2021; DOI: https://doi.org/10.4143/crt.2020.1308

Abstract PDF PubReader ePub

Purpose
Survival probability changes over time in cancer survivors. This study examined conditional survival in patients undergoing curative resection for non-small cell lung cancer (NSCLC).
Materials and Methods
Five-year conditional recurrence-free survival (CRFS), conditional overall survival (COS), and conditional relative survival (CRS) up to 10 years after surgery were calculated in patients who underwent NSCLC resection from 1994 to 2016. These rates were stratified according to age, sex, year of diagnosis, pathological stage, tumor histology, smoking status, comorbidity, and lung function.
Results
Five-year CRFS increased from 65.6% at baseline to 90.9% at 10 years after surgery. Early differences in 5-year CRFS according to stratified patient characteristics disappeared, except for age: older patients exhibited persistently lower 5-year CRFS. Five-year COS increased from 72.7% to 78.3% at 8 years and then decreased to 75.4% at 10 years. Five-year CRS increased from 79.0% at baseline to 86.8% at 10 years. Older age and higher pathologic stage were associated with lower 5-year COS and CRS up to 10 years after surgery. Female patients, those with adenocarcinoma histology, non-smokers, patient without comorbidities and had good lung function showed higher COS and CRS.
Conclusion
CRFS improved over time, but significant risk remained after 5 years. CRS slightly improved over time but did not reach 90%, suggesting significant excess mortality compared to the general population. Age and stage remained significant predictors of conditional survival several years after surgery. Our conditional survival estimates should help clinicians and patients make informed treatment and personal life decisions based on survivorship status.

Citations

Citations to this article as recorded by

Real-world treatment patterns in patients with non-metastatic non-small cell lung cancer in Greece: the ‘EVIDENCE’ study
Giannis Mountzios, Sofia Lampaki, Helena Linardou, Vassilis Georgoulias, Dimitrios Mavroudis, Stavros Anevlavis, Andriani Charpidou, Maria Lykka, Dionysis Spyratos, Evangelos G Sarris, Alvertos Somarakis, Christina Papista, Alexandros Glentis, Aristeidis
Future Oncology.2025; : 1. CrossRef
COL3A1‐positive endothelial cells influence LUAD prognosis and regulate LUAD carcinogenesis by NCL–PI3K–AKT axis
Moyan Zhang, Yicheng Liang, Peng Song
The Journal of Gene Medicine.2024;[Epub] CrossRef
Adjustment to “new normal” after cancer among non–small cell lung cancer survivors: A qualitative study
Genehee Lee, Soo Yeon Kim, Alice Ahn, Sunga Kong, Heesu Nam, Danbee Kang, Hong Kwan Kim, Young Mog Shim, Ansuk Jeong, Dong Wook Shin, Juhee Cho
Palliative and Supportive Care.2024; 22(3): 487. CrossRef
Spatial features of specific CD103+CD8+ tissue-resident memory T cell subsets define the prognosis in patients with non-small cell lung cancer
Guanqun Yang, Siqi Cai, Mengyu Hu, Chaozhuo Li, Liying Yang, Wei Zhang, Jujie Sun, Fenghao Sun, Ligang Xing, Xiaorong Sun
Journal of Translational Medicine.2024;[Epub] CrossRef
Supporting Life Adjustment in Patients With Lung Cancer Through a Comprehensive Care Program: Protocol for a Controlled Before-and-After Trial
Wonyoung Jung, Alice Ahn, Genehee Lee, Sunga Kong, Danbee Kang, Dongok Lee, Tae Eun Kim, Young Mog Shim, Hong Kwan Kim, Jongho Cho, Juhee Cho, Dong Wook Shin
JMIR Research Protocols.2024; 13: e54707. CrossRef
Conditional Survival of Patients with Limited-Stage Small Cell Lung Cancer After Surgery: A National Real-World Cohort Study
Jun-Peng Lin, Xiao-Feng Chen, Peiyuan Wang, Hao He, Wei-Jie Chen, Feng-Nian Zhuang, Hang Zhou, Yu-Jie Chen, Wen-Wei Wei, Shuo-Yan Liu, Feng Wang
Annals of Surgical Oncology.2024; 31(7): 4250. CrossRef
Cost‐Effectiveness Analysis of Adjuvant Alectinib versus Platinum‐Based Chemotherapy in Resected ALK‐Positive Non‐Small‐Cell Lung Cancer in the Chinese Health Care System
Qiran Wei, Yifang Liang, Jiahui Mao, Xin Guan
Cancer Medicine.2024;[Epub] CrossRef
Bioinformatics-based modeling of lung squamous cell carcinoma prognosis and prediction of immunotherapy response
Qiqing Zhang, Haidong He, Yi Wei, Guoping Li, Lu Shou
Discover Oncology.2024;[Epub] CrossRef
Dynamic evaluation of postoperative survival in intrahepatic cholangiocarcinoma patients who did not undergo lymphadenectomy: a multicenter study
Tingfeng Huang, Jie Kong, Hongzhi Liu, Zhipeng Lin, Qizhu Lin, Jianying Lou, Shuguo Zheng, Xinyu Bi, Jianming Wang, Wei Guo, Fuyu Li, Jian Wang, Yamin Zheng, Jingdong Li, Shi Cheng, Weiping Zhou, Yongyi Zeng
Scandinavian Journal of Gastroenterology.2023; 58(2): 178. CrossRef
A2aR on lung adenocarcinoma cells: A novel target for cancer therapy via recruiting and regulating tumor-associated macrophages
Ying Bai, Xin Zhang, Jiawei Zhou, Jianqiang Guo, Yafeng Liu, Chao Liang, Wenyang Wang, Yingru Xing, Jing Wu, Dong Hu
Chemico-Biological Interactions.2023; 382: 110543. CrossRef
Survival and Quality-of-life Outcomes in Early-Stage NSCLC Patients: a Literature Review of Real-World Evidence
Nick Jovanoski, Kathleen Bowes, Audrey Brown, Rossella Belleli, Danilo Di Maio, Shkun Chadda, Seye Abogunrin
Lung Cancer Management.2023;[Epub] CrossRef
Conditional survival analysis of patients with resected non–small cell lung cancer
Talib Chaudhry, Vaishnavi Krishnan, Andrew E. Donaldson, Zachary M. Palmisano, Sanjib Basu, Nicole M. Geissen, Justin M. Karush, Gillian C. Alex, Jeffrey A. Borgia, Michael J. Liptay, Christopher W. Seder
JTCVS Open.2023; 16: 948. CrossRef
Clinical Value of Surveillance 18F-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy
Chae Hong Lim, Soo Bin Park, Hong Kwan Kim, Yong Soo Choi, Jhingook Kim, Yong Chan Ahn, Myung-ju Ahn, Joon Young Choi
Cancers.2022; 14(3): 632. CrossRef
Primary care‐based lung and breast cancer control in China: A commentary on lessons learnt from Korea
Heng Piao, Harry H. X. Wang, Hyejin Lee, Mingyang Yu, Belong Cho
European Journal of Cancer Care.2022;[Epub] CrossRef
Conditional survival nomogram predicting real-time prognosis of locally advanced breast cancer: Analysis of population-based cohort with external validation
Xiangdi Meng, Furong Hao, Zhuojun Ju, Xiaolong Chang, Yinghua Guo
Frontiers in Public Health.2022;[Epub] CrossRef

6,857 View
169 Download
15 Web of Science
15 Crossref

Disparities in the Participation Rate of Colorectal Cancer Screening by Fecal Occult Blood Test among People with Disabilities: A National Database Study in South Korea: Dong Wook Shin, Dongkyung Chang, Jin Hyung Jung, Kyungdo Han, So Young Kim, Kui Son Choi, Won Chul Lee, Jong Heon Park, Jong Hyock Park; Cancer Res Treat. 2020;52(1):60-73. Published online May 7, 2019; DOI: https://doi.org/10.4143/crt.2018.660

Abstract PDF Supplementary Material PubReader ePub

Purpose
Implementation of screening program may lead to increased health disparity within the population if participation differs by socioeconomic status. In Korea, colorectal cancer screening is provided at no or minimal cost to all people over 50 by National Cancer Screening Program. We investigated colorectal cancer screening participation rate and its trend over the last 10 years in relation to disabilities.
Materials and Methods
We linked national disability registration data with National Cancer Screening Program data. Age, sex-standardized participation rates were analyzed by type and severity of disability for each year, and factors associated with colorectal cancer screening participation were examined by multivariate logistic regression.
Results
Age, sex-standardized participation rate in people without disability increased from 16.2 to 33.9% (change, +17.7), but it increased from 12.7% to 27.2% (change, +14.5) among people with severe disability. People with severe disabilities showed a markedly lower colorectal cancer screening participation rate than people without disability (adjusted odds ratio [aOR], 0.714; 95% confidence interval, 0.713 to 0.720). People with autism (aOR, 0.468), renal failure (aOR, 0.498), brain injury (aOR, 0.581), ostomy (aOR, 0.602), and intellectual disability (aOR, 0.610) showed the lowest participation rates.
Conclusion
Despite the availability of a National Cancer Screening Program and overall increase of its usage in the Korean population, a significant disparity was found in colorectal cancer screening participation, especially in people with severe disabilities and or several specific types of disabilities. Greater effort is needed to identify the barriers faced by these particularly vulnerable groups and develop targeted interventions to reduce inequality.

Citations

Citations to this article as recorded by

Comparative analysis of genetic testing utilization rates among people with and without disabilities in South Korea from 2016 to 2019, focusing on malignant neoplasms: A national population‐based study
Gwanwook Bang, Minji Park, Jeong‐yeon Seon, So‐Youn Park
Cancer Medicine.2024;[Epub] CrossRef
Disparities in the diagnosis and treatment of colorectal cancer among patients with disabilities
Ki Bae Kim, Dong Wook Shin, Kyoung Eun Yeob, So Young Kim, Joung-Ho Han, Seon Mee Park, Jong Heon Park, Jong Hyock Park
World Journal of Gastrointestinal Oncology.2024; 16(7): 2925. CrossRef
The effect of the expansion of the Personal Assistance Service Program on the uptake of the National Health Screening in people with severe disability
Woorim Kim, Mingee Choi, Jaeyong Shin
Journal of Public Health.2024; 46(4): 537. CrossRef
Cervical Cancer Screening and Prevention Uptake in Females with Autism Spectrum Disorder
Yachin Chen, James Powers, Christopher J. McDougle, Nicole R. Zürcher, Robyn P. Thom
Journal of Autism and Developmental Disorders.2024;[Epub] CrossRef
Disability and Participation in Colorectal Cancer Screening: A Systematic Review and Meta-Analysis
Giovanni Emanuele Ricciardi, Rita Cuciniello, Emanuele De Ponti, Carlo Lunetti, Flavia Pennisi, Carlo Signorelli, Cristina Renzi
Current Oncology.2024; 31(11): 7023. CrossRef
Family physicians’ and trainees’ experiences regarding cancer screening with patients with intellectual disability: An interpretive description study
Genevieve Breau, Sally Thorne, Jennifer Baumbusch, T Greg Hislop, Arminee Kazanjian
Journal of Intellectual Disabilities.2023; 27(1): 250. CrossRef
Type and Severity of Mental Illness and Participation in Colorectal Cancer Screening
Benedicte Kirkøen, Paula Berstad, Geir Hoff, Tomm Bernklev, Kristin R. Randel, Øyvind Holme, Thomas de Lange, Kathryn A. Robb, Edoardo Botteri
American Journal of Preventive Medicine.2023; 64(1): 76. CrossRef
Spatial and temporal patterns of colorectal cancer in Asia, 1990–2019
Rajesh Sharma, Bijoy Rakshit
International Journal of Clinical Oncology.2023; 28(2): 255. CrossRef
Uptake patterns and predictors of colorectal cancer screening among adults resident in Spain: A population-based study from 2017 to 2020
Silvia Portero de la Cruz, Jesús Cebrino
Frontiers in Public Health.2023;[Epub] CrossRef
The Korea National Disability Registration System
Miso Kim, Wonyoung Jung, So Young Kim, Jong Hyock Park, Dong Wook Shin
Epidemiology and Health.2023; 45: e2023053. CrossRef
Assessing cancer in people with profound and multiple disabilities
Daniel Satgé, Motoi Nishi, Brigitte Trétarre
BMC Cancer.2023;[Epub] CrossRef
Cancer detection, diagnosis, and treatment for adults with disabilities
Lisa I Iezzoni
The Lancet Oncology.2022; 23(4): e164. CrossRef
Mental illness and participation in colorectal cancer screening: a scoping review
Marie D. Jørgensen, Ellen M. Mikkelsen, Rune Erichsen, Mette K. Thomsen
Scandinavian Journal of Gastroenterology.2022; 57(10): 1216. CrossRef
Patients’ acceptability and implementation outcomes of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia: a qualitative secondary analysis of a mixed-method randomised clinical trial
Yuto Yamada, Masaki Fujiwara, Taichi Shimazu, Tsuyoshi Etoh, Masafumi Kodama, Ryuhei So, Takanori Matsushita, Yusaku Yoshimura, Shigeo Horii, Maiko Fujimori, Hirokazu Takahashi, Naoki Nakaya, Tempei Miyaji, Shiro Hinotsu, Keita Harada, Hiroyuki Okada, Yos
BMJ Open.2022; 12(6): e060621. CrossRef
Disability and Participation in Breast and Cervical Cancer Screening: A Systematic Review and Meta-Analysis
Fahrin Ramadan Andiwijaya, Calum Davey, Khaoula Bessame, Abdourahmane Ndong, Hannah Kuper
International Journal of Environmental Research and Public Health.2022; 19(15): 9465. CrossRef
Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway
Dan Hu, Ruo Meng, Thi Nguyen, Ok Chai, Byung Park, Ju-Seog Lee, Soo Kim
Molecular Medicine Reports.2022;[Epub] CrossRef
The Role of Disability Acceptance and Emotional Support in the Association between Negative Experiences and Depression in Disabled People with Cancer: A Moderated Mediation Model
Young Won Shin, Min Jin Jin, Myoung-Ho Hyun
STRESS.2022; 30(4): 244. CrossRef
Evaluation of health belief model-based educational intervention on colorectal cancer screening behavior at South Khorasan, Iran
Shahrbanoo Khazaei, Fatemeh Salmani, Mitra Moodi
Journal of Education and Health Promotion.2022; 11(1): 52. CrossRef
Time trends of colorectal cancer incidence and associated lifestyle factors in South Korea
Hayeong Khil, Sung Min Kim, SungEun Hong, Hyeon Min Gil, Eugene Cheon, Dong Hoon Lee, Young Ae Kim, NaNa Keum
Scientific Reports.2021;[Epub] CrossRef
Disparities in Liver Cancer Surveillance Among People With Disabilities
Jae Youn Seo, Dong Wook Shin, Su Jong Yu, Jin Hyung Jung, Kyungdo Han, In Young Cho, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
Journal of Clinical Gastroenterology.2021; 55(5): 439. CrossRef
Do cholesterol levels and continuity of statin use affect colorectal cancer incidence in older adults under 75 years of age?
Kyu-Tae Han, Seungju Kim, Antonio Palazón-Bru
PLOS ONE.2021; 16(4): e0250716. CrossRef
Disparities in prostate cancer diagnosis, treatment, and survival among men with disabilities: Retrospective cohort study in South Korea
Dong Wook Shin, Jinsung Park, Kyoung Eun Yeob, Seok Jung Yoon, Soong-nang Jang, So Young Kim, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
Disability and Health Journal.2021; 14(4): 101125. CrossRef
Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial
Masaki Fujiwara, Yuto Yamada, Taichi Shimazu, Masafumi Kodama, Ryuhei So, Takanori Matsushita, Yusaku Yoshimura, Shigeo Horii, Maiko Fujimori, Hirokazu Takahashi, Naoki Nakaya, Kyoko Kakeda, Tempei Miyaji, Shiro Hinotsu, Keita Harada, Hiroyuki Okada, Yosu
Acta Psychiatrica Scandinavica.2021; 144(4): 318. CrossRef
Population-Based Data Reveal Factors Associated with Organised and Non-Organised Colorectal Cancer Screening: An Important Step towards Improving Coverage
Thuy Ngan Tran, Guido Van Hal, Marc Peeters, Svetlana Jidkova, Harlinde De Schutter, Sarah Hoeck
International Journal of Environmental Research and Public Health.2021; 18(16): 8373. CrossRef
Disparities in the Diagnosis, Treatment, and Survival Rate of Cervical Cancer among Women with and without Disabilities
Jin Young Choi, Kyoung Eun Yeob, Seung Hwa Hong, So Young Kim, Eun-Hwan Jeong, Dong Wook Shin, Jong Heon Park, Gil-won Kang, Hak Soon Kim, Jong Hyock Park, Ichiro Kawachi
Cancer Control.2021;[Epub] CrossRef
Disparities in gastric cancer screening among people with disabilities: a national registry-linkage study in South Korea
YoungJee Kim, Dong Wook Shin, Hyoung Woo Kim, Jin Hyung Jung, Kyungdo Han, In Young Cho, So Young Kim, Kui Son Choi, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
Gastric Cancer.2020; 23(3): 497. CrossRef
Disparities in the Diagnosis and Treatment of Gastric Cancer in Relation to Disabilities
Hyoung Woo Kim, Dong Wook Shin, Kyoung Eun Yeob, In Young Cho, So Young Kim, Seon Mee Park, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
Clinical and Translational Gastroenterology.2020; 11(10): e00242. CrossRef
Trends in cancer screening rates among individuals with serious psychological distress: an analysis of data from 2007 to 2016 Japanese national surveys
Masaki Fujiwara, Yuji Higuchi, Naoki Nakaya, Maiko Fujimori, Yuto Yamada, Riho Wada, Tsuyoshi Etoh, Kyoko Kakeda, Yosuke Uchitomi, Tomio Nakayama, Norihito Yamada, Masatoshi Inagaki
Journal of Psychosocial Oncology Research & Practice.2020; 2(3): e025. CrossRef

9,938 View
243 Download
25 Web of Science
28 Crossref

The Effect of Disability on the Diagnosis and Treatment of Multiple Myeloma in Korea: A National Cohort Study: Jihyun Kwon, So Young Kim, Kyoung Eun Yeob, Hye Sook Han, Ki Hyeong Lee, Dong Wook Shin, Yeon-Yong Kim, Jong Heon Park, Jong Hyock Park; Cancer Res Treat. 2020;52(1):1-9. Published online April 22, 2019; DOI: https://doi.org/10.4143/crt.2018.702

Abstract PDF Supplementary Material PubReader ePub

Purpose
This study aimed to determine whether the diagnosis, treatment approach, and prognosis of multiple myeloma (MM) vary according to the presence and type of disability.
Materials and Methods
Demographic, socioeconomic, and medical data were obtained from the National Disability Database, the Korean Central Cancer Registry, and the Korean National Health Insurance claims database. An age- and sex-matched cohort was established using a 1:3 ratio constituted with 2,776,450 people with disabilities and 8,329,350 people without disabilities. Adult patients diagnosed with MM were subsequently selected from this cohort. Disabilities were categorized as physical, communication, intellectual or psychological, and affecting the major internal organs.
Results
The cohort included 4,090 patients with MM, with a significantly lower rate per 100,000 persons among people with disabilities than among people without disabilities (29.1 vs. 39.4, p < 0.001). People with disabilities were more likely to undergo dialysis treatment at the time of diagnosis (16.3% vs. 10.0%, p < 0.001), but were less likely to undergo autologous stem cell transplantation (37.5% vs. 43.7%, p=0.072). This trend was more evident among patients with intellectual or psychological disabilities. The median overall survival among patients with disabilities was significantly shorter than that among patients without disabilities (36.8 months vs. 51.2 months, p < 0.001).
Conclusion
In Korea, people with disabilities generally have a lower rate of MM diagnosis, receive less intensive treatment, and have a lower survival rate than people without disabilities.

Citations

Citations to this article as recorded by

Case report: IORT as an alternative treatment option for breast cancer patients with difficulty staying still
Fardeen Bhimani, Maureen McEvoy, Yu Chen, Anjuli Gupta, Jessica Pastoriza, Shani Fruchter, Zachary C. Bitan, Wolfgang A. Tomé, Keyur Mehta, Jana Fox, Sheldon Feldman
Frontiers in Oncology.2024;[Epub] CrossRef
The Korea National Disability Registration System
Miso Kim, Wonyoung Jung, So Young Kim, Jong Hyock Park, Dong Wook Shin
Epidemiology and Health.2023; 45: e2023053. CrossRef
Do people with disabilities experience disparities in cancer care? A systematic review
Irene Tosetti, Hannah Kuper, Sina Azadnajafabad
PLOS ONE.2023; 18(12): e0285146. CrossRef
Cancer detection, diagnosis, and treatment for adults with disabilities
Lisa I Iezzoni
The Lancet Oncology.2022; 23(4): e164. CrossRef
Disparities in All-Cause Mortality in Older Patients with Colorectal Cancer According to Disability Status: A Nationwide Analysis
Woo-Ri Lee, Kyu-Tae Han, Mingee Choi, Woorim Kim
Current Oncology.2022; 29(10): 7430. CrossRef
Disparities in prostate cancer diagnosis, treatment, and survival among men with disabilities: Retrospective cohort study in South Korea
Dong Wook Shin, Jinsung Park, Kyoung Eun Yeob, Seok Jung Yoon, Soong-nang Jang, So Young Kim, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
Disability and Health Journal.2021; 14(4): 101125. CrossRef
Disparities in the Diagnosis, Treatment, and Survival Rate of Cervical Cancer among Women with and without Disabilities
Jin Young Choi, Kyoung Eun Yeob, Seung Hwa Hong, So Young Kim, Eun-Hwan Jeong, Dong Wook Shin, Jong Heon Park, Gil-won Kang, Hak Soon Kim, Jong Hyock Park, Ichiro Kawachi
Cancer Control.2021;[Epub] CrossRef
Disparities in the Diagnosis and Treatment of Gastric Cancer in Relation to Disabilities
Hyoung Woo Kim, Dong Wook Shin, Kyoung Eun Yeob, In Young Cho, So Young Kim, Seon Mee Park, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
Clinical and Translational Gastroenterology.2020; 11(10): e00242. CrossRef

9,501 View
365 Download
7 Web of Science
8 Crossref

Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study: Dong Wook Shin, Sang Hyub Lee, Tae-Hwan Kim, Seok Joong Yun, Jong Kil Nam, Seung Hyun Jeon, Seung Chol Park, Seung Il Jung, Jong-Hyock Park, Jinsung Park; Cancer Res Treat. 2019;51(2):556-567. Published online July 16, 2018; DOI: https://doi.org/10.4143/crt.2018.221

Abstract PDF Supplementary Material PubReader ePub

Purpose
Health-related quality of life (HRQOL) information related to radical prostatectomy (RP) is valuable for prostate cancer (PC) patients needing to make treatment decisions. We aimed to investigate HRQOL change in PC patients who underwent three types of RP (open, laparoscopic, or robotic) and compared their HRQOL with that of general population.
Materials and Methods
Patients were prospectively recruited between October 2014 and December 2015. European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire (EORTC QLQ-C30) and PC-specific module (PR25) were administered before surgery (baseline) and at postoperative 3 and 12 months. At each time point, HRQOL was compared, and a difference of 10 out of 0-100 scale was considered clinically significant.
Results
Among 258 screened patients, 209 (41 open, 63 laparoscopic, and 105 robotic surgeries) were included. Compared to baseline, physical, emotional, and cognitive functioning improved at 12 months. Role functioning worsened at 3 months, but recovered to baseline at 12 months. Pain, insomnia, diarrhea, and financial difficulties also significantly improved at 12 months. Most PR25 scales excluding bowel symptoms deteriorated at 3 months. Urinary symptoms and incontinence aid recovered at 12 months, whereas sexual activity and sexual function remained poor at 12 months. Clinically meaningful differences in HRQOL were not observed according to RP modalities. Compared to the general population, physical and role functioning were significantly lower at 3 months, but recovered by 12 months. Social functioning did not recover.
Conclusion
Most HRQOL domains showed recovery within 12 months after RP, excluding sexual functioning and social functioning. Our findings may guide patients considering surgical treatment for PC.

Citations

Citations to this article as recorded by

Quality of life after robotic versus conventional minimally invasive cancer surgery: a systematic review and meta-analysis
Russell Seth Martins, Asad Saulat Fatimi, Omar Mahmud, Muhammad Umar Mahar, Arshia Jahangir, Kinza Jawed, Shalni Golani, Ayra Siddiqui, Syed Roohan Aamir, Ali Ahmad
Journal of Robotic Surgery.2024;[Epub] CrossRef
The Effect of Discharge Education and Post-Discharge Telephone Counseling on Quality of Life in Patients Undergoing Radical Prostatectomy: A Randomized Controlled Study
İpek Köse Tosunöz, Sevgi Deniz Doğan, Şeyma Yurtseven, Sevban Arslan
Cukurova Anestezi ve Cerrahi Bilimler Dergisi.2024; 7(3): 205. CrossRef
Health‐related quality of life the first year after a prostate cancer diagnosis a systematic review
Louise Dorner Østergaard, Mads Hvid Poulsen, Malene Eiberg Jensen, Lars Lund, Malene Grubbe Hildebrandt, Birgitte Nørgaard
International Journal of Urological Nursing.2023; 17(1): 15. CrossRef
Quantitative Analysis of Quality of Life and Exploration of Influencing Factors in Patients Undergoing Radical Prostatectomy
Feiyang Wang, Jiajun Chen, Weihao Wang, Mengyao Li, Chao Peng, Shouhua Pan, Chuanchuan Zhan, Keyuan Zhao, Yulei Li, Lulu Zhang, Gang Xu, Jing Jin
Urology.2023; 181: 105. CrossRef
Effects of omega‐3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double‐blind placebo‐controlled randomized trial
Josée Savard, Hanane Moussa, Jean‐François Pelletier, Pierre Julien, Louis Lacombe, Rabi Tiguert, Yves Caumartin, Thierry Dujardin, Paul Toren, Frédéric Pouliot, Michele Lodde, Yves Fradet, Karine Robitaille, Vincent Fradet
Cancer Medicine.2023; 12(19): 20163. CrossRef
Treatment Outcomes and Its Associated Factors Among Adult Patients with Selected Solid Malignancies at Kenyatta National Hospital: A Hospital-Based Prospective Cohort Study
Amsalu Degu, Ermias Mergia Terefe, Eliab Seroney Some, Gobezie T Tegegne
Cancer Management and Research.2022; Volume 14: 1525. CrossRef
A systematic review of supervised comprehensive functional physiotherapy after radical prostatectomy
B. Steenstrup, M. Cartier, F.X. Nouhaud, G. Kerdelhue, M. Gilliaux
Progrès en Urologie.2022; 32(7): 525. CrossRef
Perioperative psychological issues and nursing care among patients undergoing minimally invasive surgeries
Kehua Yang, Xu Shao, Xinghui Lv, Feimin Yang, Qunyan Shen, Jing Fang, Wei Chen
Laparoscopic, Endoscopic and Robotic Surgery.2022; 5(3): 92. CrossRef
A Survey on the Quality of Life of Prostate Cancer Patients in Korean Prostate Cancer Patients Association
Yun-Sok Ha, Kwang Taek Kim, Wook Nam, Hongzoo Park, Sangjun Yoo, Chan Ho Lee, Ho Seok Chung, Woo Suk Choi, Jiyoun Kim, Jaeeun Shin, Jeong Hyun Kim, Cheol Kwak
The Korean Journal of Urological Oncology.2022; 20(4): 265. CrossRef
Effects of leuprolide acetate on the quality of life of patients with prostate cancer: A prospective longitudinal cohort study
Myung Soo Kim, Seung Il Jung, Ho Seok Chung, Eu Chang Hwang, Dongdeuk Kwon
Prostate International.2021; 9(3): 132. CrossRef
Quality of life assessment using EORTC QLQ questionnaires in the prostate cancer population treated with radical prostatectomy: a systematic review
Tomasz Jurys, Jacek Durmala
Scandinavian Journal of Urology.2021; 55(2): 90. CrossRef
Évaluation de l’observance et de l’adhésion thérapeutique de deux protocoles de rééducation après prostatectomie
Benoit Steenstrup, Claire Breton, Guillaume Galliou, François-Xavier Nouhaud
Kinésithérapie, la Revue.2021; 21(234): 12. CrossRef
Metabolic syndrome, levels of androgens, and changes of erectile dysfunction and quality of life impairment 1 year after radical prostatectomy
Yann Neuzillet, Mathieu Rouanne, Jean-François Dreyfus, Jean-Pierre Raynaud, Marc Schneider, Morgan Roupret, Sarah Drouin, Marc Galiano, Xavier Cathelinau, Thierry Lebret, Henry Botto
Asian Journal of Andrology.2021; 23(4): 370. CrossRef
The Effect of Post-prostatectomy Urinary Incontinence on Health-related Quality of Life in Patients with Prostate Cancer
Jeong Hyun Kim, Yeon Soo Jang, Young Deuk Choi, Eui Geum Oh
Korean Journal of Adult Nursing.2019; 31(3): 293. CrossRef
Prostate-specific health-related quality of life and patient-physician communication — A 3.5-year follow-up
Nicole Ernstmann, Jan Herden, Lothar Weissbach, André Karger, Kira Hower, Lena Ansmann
Patient Education and Counseling.2019; 102(11): 2114. CrossRef

10,066 View
294 Download
14 Web of Science
15 Crossref

Increased Risk of Osteoporosis in Gastric Cancer Survivors Compared to General Population Control: A Study with Representative Korean Population: Su-Min Jeong, Dong Wook Shin, Ji Eun Lee, Sang-Man Jin, Sung Kim; Cancer Res Treat. 2019;51(2):530-537. Published online June 27, 2018; DOI: https://doi.org/10.4143/crt.2018.164

Abstract PDF Supplementary Material PubReader ePub

Purpose
Although several studies have suggested that osteoporosis is common in survivors of gastric cancer (GC), no study to date has directly assessed the risk for osteoporosis in GC survivors compared to matched controls. Thus, we aimed to investigate the relative risk for osteoporosis in survivors of GC compared to general population.
Materials and Methods
We used the Korea National Health and Nutrition Examination Survey data (2008-2011). Patients with a history of GC (n=94) were defined as case among 8,142 individuals over 50 years old who were evaluated by dual-energy X-ray absorptiometry. Controls (n=470) were matched to cases by age and sex in a 1:5 ratio. Osteopenia (–2.5 < T-score < –1.0) and osteoporosis (T-score ≤ –2.5) were defined.
Results
The prevalence of osteoporosis in GC survivors was 30.2%, which was significantly greater than that of controls (19.7%). In total, GC survivors had a 3.7-fold increased risk for osteoporosis compared to controls (p=0.021). In addition, the risk for osteoporosis of the total proximal femur total (TF) and femur neck (FN) was significantly increased among GC survivors compared to controls (adjusted relative risk, 4.64; 95% confidence interval, 1.16 to 18.6 in TF and adjusted relative risk, 3.58; 95% confidence interval, 1.19 to 10.8 in FN). Furthermore, we found sub-optimal daily calcium intake and mean serum levels of 25-hydroxy-vitamin D in both groups.
Conclusion
GC survivors are at significantly increased risk for osteoporosis, especially in the femur. Clinically, our finding supports the importance of screening bone health and adequate nutrient supplementation in survivors of GC.

Citations

Citations to this article as recorded by

Senolytic treatment alleviates doxorubicin‐induced chemobrain
Vivekananda Budamagunta, Ashok Kumar, Asha Rani, Sahana Manohar Sindhu, Yang Yang, Daohong Zhou, Thomas C. Foster
Aging Cell.2024;[Epub] CrossRef
Association between Gastric Cancer and Osteoporosis: A Longitudinal Follow-Up Study Using a National Health Sample Cohort
Kyeong Min Han, Mi Jung Kwon, Joo-Hee Kim, Ji Hee Kim, Woo Jin Bang, Hyo Geun Choi, Dae Myoung Yoo, Na-Eun Lee, Nan Young Kim, Ho Suk Kang
Cancers.2024; 16(13): 2291. CrossRef
Preoperative abnormal bone mineral density as a prognostic indicator in patients undergoing gastrectomy for gastric cancer: A cohort study
Soomin An, Wankyu Eo
Medicine.2024; 103(21): e38251. CrossRef
The risk of osteoporotic fracture in gastric cancer survivors: total gastrectomy versus subtotal gastrectomy versus endoscopic treatment
HyunJin Oh, Byung-Ho Yoon, Jung-Wee Park, Ye Jhin Jeon, Bit-Na Yoo, Jean Kyung Bak, Yong-Chan Ha, Young-Kyun Lee
Gastric Cancer.2023; 26(5): 814. CrossRef
Factors Associated with Dietary Habit Changes in Korean Stomach Cancer Survivors after Cancer Treatment
Junhee Park, Jiyoung Kim, Dong Wook Shin, Jinyoung Shin, Belong Cho, Yun-Mi Song
Nutrients.2023; 15(14): 3268. CrossRef
Bone Fragility in Gastrointestinal Disorders
Daniela Merlotti, Christian Mingiano, Roberto Valenti, Guido Cavati, Marco Calabrese, Filippo Pirrotta, Simone Bianciardi, Alberto Palazzuoli, Luigi Gennari
International Journal of Molecular Sciences.2022; 23(5): 2713. CrossRef
Vitamin D—The Nutritional Status of Post-Gastrectomy Gastric Cancer Patients—Systematic Review
Tomasz Muszyński, Karina Polak, Aleksandra Frątczak, Bartosz Miziołek, Beata Bergler-Czop, Antoni Szczepanik
Nutrients.2022; 14(13): 2712. CrossRef
Bone Loss in Patients with Pancreatic Neuroendocrine Tumors
He Tong, Miaomiao Wang, Jingjing Liu, Chuangen Guo, Zhongqiu Wang, Jianhua Wang, Xiao Chen
Journal of Clinical Medicine.2022; 11(22): 6701. CrossRef
The risk of osteoporotic fractures after gastrectomy: Findings from the Korean national sample cohort database (2002-2019)
Il Yun, Kyungduk Hurh, Sung Hoon Jeong, Eun-Cheol Park, Sung-In Jang
Frontiers in Oncology.2022;[Epub] CrossRef
Incidence and risk factors of osteoporotic status in outpatients who underwent gastrectomy for gastric cancer
Tsutomu Namikawa, Keiichiro Yokota, Jun Iwabu, Masaya Munekage, Sunao Uemura, Shigehiro Tsujii, Hiromichi Maeda, Hiroyuki Kitagawa, Takashi Karashima, Masamitsu Kumon, Keiji Inoue, Michiya Kobayashi, Kazuhiro Hanazaki
JGH Open.2020; 4(5): 903. CrossRef
Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review)
Leon Fisher, Alexander Fisher, Paul N Smith
Journal of Clinical Medicine.2020; 9(10): 3253. CrossRef
Increased Risk of Osteoporotic Fracture in Postgastrectomy Gastric Cancer Survivors Compared With Matched Controls: A Nationwide Cohort Study in Korea
Dong Wook Shin, Beomseok Suh, Hyunsun Lim, Yun-Suhk Suh, Yoon Jin Choi, Su-Min Jeong, Jae Moon Yun, Sun Ok Song, Youngmin Park
American Journal of Gastroenterology.2019; 114(11): 1735. CrossRef

8,670 View
163 Download
13 Web of Science
12 Crossref

Health-Related Quality of Life, Perceived Social Support, and Depression in Disease-Free Survivors Who Underwent Curative Surgery Only for Prostate, Kidney and Bladder Cancer: Comparison among Survivors and with the General Population: Dong Wook Shin, Hyun Sik Park, Sang Hyub Lee, Seung Hyun Jeon, Seok Cho, Seok Ho Kang, Seung Chol Park, Jong Hyock Park, Jinsung Park; Cancer Res Treat. 2019;51(1):289-299. Published online May 4, 2018; DOI: https://doi.org/10.4143/crt.2018.053

Abstract PDF PubReader ePub

Purpose
The purpose of this study was to compare health-related quality of life (HRQoL) of disease-free prostate (PC), kidney (KC), and bladder cancer (BC) survivors with that of the general population.
Materials and Methods
Our study included 331 urological cancer (UC) survivors (114 PC, 108 KC, and 109 BC) aged ≥ 50 years disease-free for at least 1 year after surgery. The control group included 1,177 subjects without a history of cancer. The HRQoL was assessed using the European Organization for Research and Treatment of Cancer QLQ-C30, the Duke-UNC Functional Social Support Questionnaire, and the Patient Health Questionnaire-9.
Results
There was no significant difference between the groups in terms of any of the functioning sub-scales and symptoms, except significantly lower social functioning observed in BC survivors than that observed in KC survivors. Although the three groups of UC survivors showed essentially similar functioning sub-scales and symptoms when compared to the general population, PC and BC survivors showed significantly lower social functioning and a lower appetite than that observed in controls. KC survivors showed lower physical functioning, as well as higher pain and dyspnea. Although all three groups of UC survivors reported higher financial difficulties, they also reported higher perceived social support than that reported by the non-cancer control group. No statistically significant difference was observed in terms of depressive symptoms between each group of UC survivors and the general population.
Conclusion
Disease-free survivors of the three major types of UCs showed generally similar HRQoL compared to the general population, as well as compared to each other.

Citations

Citations to this article as recorded by

Role performance and factors affecting quality of life in bladder cancer survivors with ileal orthotopic neobladder
So Hee Kim, Eunjung Ryu, Byong Chang Jeong
Asia-Pacific Journal of Oncology Nursing.2024; 11(6): 100490. CrossRef
The mental and emotional status after radical cystectomy and different urinary diversion orthotopic bladder substitution versus external urinary diversion after radical cystectomy: A propensity score‐matched study
Giuseppe Palermo, Francesco Pio Bizzarri, Eros Scarciglia, Emilio Sacco, Koosha Moosavi Seyed, Pierluigi Russo, Filippo Gavi, Battista Filomena Giovanni, Francesco Rossi, Marco Campetella, Angelo Totaro, Nazario Foschi, Marco Racioppi
International Journal of Urology.2024; 31(12): 1423. CrossRef
Factors Affecting the Health-Related Quality of Life of Patients with Bladder Cancer
Haetsal Kwon, Hyojung Park
Journal of Korean Public Health Nursing.2024; 38(3): 358. CrossRef
Properties of the Shift and Persist Questionnaire in adolescent and young adult cancer patients and survivors: Validity, consistency, and interpretability
Karly M. Murphy, Edith Chen, Edward H. Ip, Abby R. Rosenberg, Mallory A. Snyder, John M. Salsman
Quality of Life Research.2023; 32(1): 273. CrossRef
Adoption of patient communication rules in clinical practice and the role of faith-based communities in shaping them: the palliative aspect of spiritual support
Konstantin Sokolovskiy, Olga Pashanova, Vladimir Beketov, Andrey Aleshkin
Mental Health, Religion & Culture.2023; 26(1): 16. CrossRef
Identifying the unmet supportive care needs of people affected by kidney cancer: a systematic review
Amy O’Dea, Craig Gedye, Belinda Jago, Catherine Paterson
Journal of Cancer Survivorship.2022; 16(6): 1279. CrossRef
Mental Health in Urologic Oncology
Danyon Anderson, Abrahim N. Razzak, Matthew McDonald, David Cao, Jamal Hasoon, Omar Viswanath, Alan D. Kaye, Ivan Urits
Health Psychology Research.2022;[Epub] CrossRef
Psychological Distress in Patients Treated for Renal Cell Carcinoma: A Systematic Literature Review
Liliana Vartolomei, Manuela Schmidinger, Mihai Vartolomei, Shahrokh Shariat
Journal of Clinical Medicine.2022; 11(21): 6383. CrossRef
Health-Related Quality of Life among Cancer Survivors Depending on the Occupational Status
Kisook Kim, Hyohyeon Yoon
International Journal of Environmental Research and Public Health.2021; 18(7): 3803. CrossRef
Feasibility of a socio-spiritual intervention to improve quality of life of adult Nigerians with cancer and their family caregivers: Protocol for a randomised controlled trial
Israel Gabriel, Debra Creedy, Elisabeth Coyne
Contemporary Clinical Trials Communications.2021; 22: 100802. CrossRef
Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls—results from a population-based study
Salome Adam, Daniela Doege, Lena Koch-Gallenkamp, Melissa S. Y. Thong, Heike Bertram, Andrea Eberle, Bernd Holleczek, Ron Pritzkuleit, Mechthild Waldeyer-Sauerland, Annika Waldmann, Sylke Ruth Zeissig, Lina Jansen, Sabine Rohrmann, Hermann Brenner, Volker
Supportive Care in Cancer.2020; 28(6): 2875. CrossRef
Comorbid depression in medical diseases
Stefan M. Gold, Ole Köhler-Forsberg, Rona Moss-Morris, Anja Mehnert, J. Jaime Miranda, Monika Bullinger, Andrew Steptoe, Mary A. Whooley, Christian Otte
Nature Reviews Disease Primers.2020;[Epub] CrossRef
Health-related Quality of Life and Its Related Factors among Cancer Survivors and General Adults: Focusing on Lifestyle Behaviors and Mental Health
Eun A Song, Youngran Kweon, Yoon Young Hwang, Minjeong An
Korean Journal of Adult Nursing.2020; 32(4): 385. CrossRef
Age and gender differences in anxiety and depression in cancer patients compared with the general population
Andreas Hinz, Philipp Yorck Herzberg, Florian Lordick, Joachim Weis, Hermann Faller, Elmar Brähler, Martin Härter, Karl Wegscheider, Kristina Geue, Anja Mehnert
European Journal of Cancer Care.2019;[Epub] CrossRef

12,093 View
216 Download
12 Web of Science
14 Crossref

Patient’s Cognitive Function and Attitudes towards Family Involvement in Cancer Treatment Decision Making: A Patient-Family Caregiver Dyadic Analysis: Dong Wook Shin, Juhee Cho, Debra L. Roter, So Young Kim, Jong Hyock Park, Hyung Kook Yang, Hyun Woo Lee, Sun-Seog Kweon, Yune Sik Kang, Keeho Park; Cancer Res Treat. 2018;50(3):681-690. Published online July 4, 2017; DOI: https://doi.org/10.4143/crt.2017.201

Abstract PDF PubReader ePub

Purpose
Older patient populations commonly have cognitive impairment, which might impact decisional capacity. We examined patients and family caregivers preferences for family involvement in treatment decision making assuming different level of cognitive impairment, and sought to explore the factors associated with the preferences and the degree to which patients and family members agree on preferences.
Materials and Methods
A total of 358 elderly cancer patient and caregiver dyads were recruited from the 11 cancer centers in Korea andwere asked to express their preferences forfamily involvement in treatment decision making using hypothetical scenarios with three different levels of cognitive status (intact, mild impairment, and severe impairment).
Results
Both patients and family caregivers preferred greater family dominance in treatment decision makingwith the increasing the level of cognitive impairment (39.7%, 60.9%, and 86.6% for patients and 45.0%, 66.2%, and 89.7% for caregivers in each scenarios). Patient and family caregiver concordance in decisional control preference was small for all three scenarios (weighted κ=0.32, κ=0.26, and κ=0.36, respectively). Higher patient education was associated with preference for patient dominance in treatment decision in conditions of both mild and severe cognitive impairment. The association of higher patient education and patient-caregiver preference concordance was positive with intact cognition, while it was negative with severe cognitive impairment.
Conclusion
Decision control preferences were affected by hypothesized cognitive status of the patients. Findings from our study would be helpful to develop effective strategy for optimizing family involvement in cancer treatment decision in the context of deteriorating cognitive function of the patients.

Citations

Citations to this article as recorded by

Comorbid Dementia and Cancer Therapy Decision-Making: A Scoping Review
Sean N. Halpin, Gabriel Alain, Aaron Seaman, Erin E. Stevens, Hui Zhao, Mackenzie E. Fowler, Qiuyang Zhang, Tamara Cadet, Minzhi Ye, Jessica L. Krok-Schoen
Journal of Applied Gerontology.2024; 43(8): 1132. CrossRef
Assessing the association between quantity and quality of family caregiver participation in decision-making clinical encounters on patient activation in the metastatic breast cancer setting
Nicole L. Henderson, Tanvi Padalkar, Garrett Bourne, Emma K. Hendrix, Courtney P. Williams, J. Nicholas Odom, Kristen Triebel, Gabrielle B. Rocque
Supportive Care in Cancer.2024;[Epub] CrossRef
Fatalism and metaphor in Confucianism: A qualitative study of barriers to genetic testing among first‐degree relatives of hereditary cancer patients from China
Chaonan Jiang, Li Liu, Ye Wang, Liangzheng Wu, Wenxia Zhang, Xiaodan Wu
Psycho-Oncology.2023; 32(2): 275. CrossRef
The Role of Nurse on the Treatment Decision Support for Older People with Cancer: A Systematic Review
Hiroko Komatsu, Yasuhiro Komatsu
Healthcare.2023; 11(4): 546. CrossRef
A prospective cohort study of decision‐making role preferences of patients with advanced cancer and their family caregivers
Semra Ozdemir, Sean Ng, Isha Chaudhry, Chetna Malhotra, Eric Andrew Finkelstein
Cancer.2023; 129(9): 1443. CrossRef
Cancer literacy among Jordanian colorectal cancer survivors and informal carers: Qualitative explorations
Samar J. Melhem, Shereen Nabhani-Gebara, Reem Kayyali
Frontiers in Public Health.2023;[Epub] CrossRef
Preferred and actual involvement of caregivers in oncologic treatment decision-making: A systematic review
Laura M.L. Tielemans, Kirsten D. van Heugten, Marije E. Hamaker, Inez C. van Walree
Journal of Geriatric Oncology.2023; 14(6): 101525. CrossRef
Factors Affecting Patient and Caregiver Preferences for Treatment of Myeloma and Indolent Lymphoma
Chia Jie Tan, Melinda Si Yun Tan, Chandramouli Nagarajan, Wee Joo Chng, Yen-Lin Chee, Melissa Ooi, Lawrence Cheng Kiat Ng, Yunxin Chen, Joanne Su Yin Yoong, Xin Yi Wong, Wei-Ying Jen
JCO Oncology Practice.2023; 19(12): 1168. CrossRef
The Association Between Mild Cognitive Impairment Diagnosis and Patient Treatment Preferences: a Survey of Older Adults
Deborah A. Levine, Andrzej T. Galecki, Brenda L. Plassman, Angela Fagerlin, Lauren P. Wallner, Kenneth M. Langa, Rachael T. Whitney, Brahmajee K. Nallamothu, Lewis B. Morgenstern, Bailey K. Reale, Emilie M. Blair, Bruno Giordani, Kathleen Anne Welsh-Bohme
Journal of General Internal Medicine.2022; 37(8): 1925. CrossRef
Patient activation and treatment decision-making in the context of cancer: examining the contribution of informal caregivers’ involvement
Chiara Acquati, Judith H. Hibbard, Ellen Miller-Sonet, Anao Zhang, Elena Ionescu
Journal of Cancer Survivorship.2022; 16(5): 929. CrossRef
Factors influencing family involvement in treatment decision-making for older patients with cancer: A scoping review
Bea L. Dijkman, Marie Louise Luttik, Hanneke Van der Wal-Huisman, Wolter Paans, Barbara L. van Leeuwen
Journal of Geriatric Oncology.2022; 13(4): 391. CrossRef
The role of caregivers in the clinical pathway of patients newly diagnosed with breast and prostate cancer: A study protocol
Clizia Cincidda, Serena Oliveri, Virginia Sanchini, Gabriella Pravettoni
Frontiers in Psychology.2022;[Epub] CrossRef
Treatment decision-making for older adults with cancer: A qualitative study
Ni Gong, Qianqian Du, Hongyu Lou, Yiheng Zhang, Hengying Fang, Xueying Zhang, Xiaoyu Wu, Ya Meng, Meifen Zhang
Nursing Ethics.2021; 28(2): 242. CrossRef
Family Caregiving Situations and Engagement in Advance Care Planning
Kyeongmo Kim, Michin Hong, Thomas Buckley
Journal of Palliative Medicine.2020; 23(1): 125. CrossRef
What We Talk about When We Talk about Caregiving: The Distribution of Roles in Cancer Patient Caregiving in a Family-Oriented Culture
Ansuk Jeong, Dongwook Shin, Jong Hyock Park, Keeho Park
Cancer Research and Treatment.2019; 51(1): 141. CrossRef
Experience with age discrimination and attitudes toward ageism in older patients with cancer and their caregivers: A nationwide Korean survey
Dong Wook Shin, Keeho Park, Ansuk Jeong, Hyung Kook Yang, So Young Kim, Mihee Cho, Jong Hyock Park
Journal of Geriatric Oncology.2019; 10(3): 459. CrossRef
How family caregivers of persons with advanced cancer assist with upstream healthcare decision-making: A qualitative study
J. Nicholas Dionne-Odom, Deborah Ejem, Rachel Wells, Amber E. Barnato, Richard A. Taylor, Gabrielle B. Rocque, Yasemin E. Turkman, Matthew Kenny, Nataliya V. Ivankova, Marie A. Bakitas, Michelle Y. Martin, Mojtaba Vaismoradi
PLOS ONE.2019; 14(3): e0212967. CrossRef

10,705 View
231 Download
17 Web of Science
17 Crossref

Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24: Jinsung Park, Dong Wook Shin, Tae-Hwan Kim, Seung Il Jung, Jong Kil Nam, Seung Chol Park, Sungwoo Hong, Jae Hung Jung, Hongwook Kim, Won Tae Kim; Cancer Res Treat. 2018;50(1):40-49. Published online March 10, 2017; DOI: https://doi.org/10.4143/crt.2016.594

Abstract PDF PubReader ePub

Purpose
We aimed to evaluate psychometric properties of the Korean version of the EORTC QLQ-NMIBC24 when applied to Korean non-muscle invasive bladder cancer (NMIBC) patients.
Materials and Methods
A total of 249 patients who underwent curative transurethral resection of bladder tumor (TURBT) for primary orrecurrentNMIBCwere asked to complete theKorean version of EORTC QLQ-C30 and -NMIBC24 questionnaires three times (preoperative, post-TURBT 3 months and 6 months). Linguistic validation and psychometric evaluation of the questionnaire was conducted.
Results
Multitrait scaling analysis confirmed satisfactory construct validity in five scales except the malaise scale. Internal consistency was good (Cronbach’s alpha ≥ 0.70) for the five scales except the malaise scale at the all three time points. Known-group comparison analyses showed better quality-of-life (QOL) scores in patients with higher performance status as expected, and better sexual function in men than women (p < 0.05). Most of the scales had low correlations (< 0.40) with the scales in QLQ-C30 showing divergent validity, except for malaise scale which showed higher correlations (0.42 to 0.60). Responsiveness to change was consistent with clinical implications over time after TURBT.
Conclusion
The Korean version of the EORTC QLQ-NMIBC24 has good reliability and cross-cultural validity for measuring various QOL aspects that can be self-administered to Korean NMIBC patients undergoing TURBT.

Citations

Citations to this article as recorded by

Health-related Quality of Life During the First 4 Years After Non–Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort
Ivy Beeren, Nena E. Klerks, Katja K. Aben, Jorg R. Oddens, J. Alfred Witjes, Lambertus A. Kiemeney, Alina Vrieling
European Urology Oncology.2024; 7(4): 829. CrossRef
The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review
E. Rammant, L. Fox, K. Beyer, N. K. Aaronson, R. Chaloner, S. De Padova, F. Liedberg, L. M. Wintner, K. Decaestecker, V. Fonteyne, N. Perdek, H. Wylie, J. W. F. Catto, T. M. Ripping, B. Holzner, M. Van Leeuwen, M. Van Hemelrijck
Quality of Life Research.2023; 32(8): 2127. CrossRef
Quality of life in bladder cancer: systematic review and meta-analysis
Sima Rafiei, Golnaz Kheradkhah, Grigorios Kotronoulas, Maryam Doustmehraban, Farnoosh Shafiei, Maryam Masoumi, Elaheh Parnian, Elmira Nosrati Sanjabad, Ahmad Ghashghaee
BMJ Supportive & Palliative Care.2023; 13(e3): e707. CrossRef
Quality of life patterns and its association with predictors among non-muscle invasive bladder cancer survivors: A latent profile analysis
Jeongok Park, Young Deuk Choi, Kyoungjin Lee, Miae Seo, Ahyoung Cho, Sejeong Lee, Keum-hee Nam
Asia-Pacific Journal of Oncology Nursing.2022; 9(6): 100063. CrossRef
Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer
T. M. Ripping, E. Rammant, J. A. Witjes, N. K. Aaronson, M. van Hemelrijck, L. M. C. van Hoogstraten, J. Boormans, C. A. Goossens, A. G. van der Heijden, M. C. C. M. Hulshof, G. J. L. H. van Leenders, A. M. van Leliveld, R. P. Meijer, R. J. A. van Moorsel
Health and Quality of Life Outcomes.2022;[Epub] CrossRef
Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer
Theodora M. Ripping, Ellen Westhoff, Neil K. Aaronson, Mieke Van Hemelrijck, Elke Rammant, J. Alfred Witjes, Lambertus. A. Kiemeney, Katja K. H. Aben, Alina Vrieling
Journal of Patient-Reported Outcomes.2021;[Epub] CrossRef
Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews

Lauren J Lee, Christina S Kwon, Anna Forsythe, Carla M Mamolo, Elizabeth T Masters, Ira A Jacobs
ClinicoEconomics and Outcomes Research.2020; Volume 12: 693. CrossRef
Effect of a patient education and rehabilitation program on anxiety, depression and quality of life in muscle invasive bladder cancer patients treated with adjuvant chemotherapy
Zhonghui Li, Dan Wei, Chenxi Zhu, Qing Zhang
Medicine.2019; 98(44): e17437. CrossRef

8,955 View
302 Download
13 Web of Science
8 Crossref

Changing Patterns of Primary Treatment in Korean Men with Prostate Cancer Over 10 Years: A Nationwide Population Based Study: Jinsung Park, Beomseok Suh, Dong Wook Shin, Jun Hyuk Hong, Hanjong Ahn; Cancer Res Treat. 2016;48(3):899-906. Published online October 20, 2015; DOI: https://doi.org/10.4143/crt.2015.212

Abstract PDF PubReader ePub

Purpose
We investigated changing patterns of primary treatment in Korean men with prostate cancer (PC) and impact of sociodemographic factors on treatment choice from a nationwide cohort over 10 years. Materials and Methods We conducted a cohort study of a 2% nationwide random sample of Korean National Health Insurance. A total of 1,382 patients who had undergone active treatments for newly diagnosed PC between 2003 and 2013 were included. Time trends in primary treatment of PC, including radical surgery, radiation therapy (RT), and androgen deprivation therapy (ADT) were analyzed.
Results
Total number of patients undergoing active treatments increased significantly (162%). Surgery cases showed the most significant increase, from 22.4% in 2003 to 45.4% in 2013, while the relative proportion of ADT showed a tendency to decrease from 60.3% in 2003 to 45.4% in 2013, and the relative proportion of RT was variable over 10 years (from 7.2% to 18.4%). While treatment patterns differed significantly according to age (p < 0.001) and income classes (p=0.014), there were differences in primary treatment according to residential area. In multinomial logistic regression analysis, older patients showed significant association with ADT or RT compared to surgery, while patients with higher income showed significant association with surgery. Conclusion Treatment pattern in Korean PC patients has changed remarkably over the last 10 years. Sociodemographic factors do affect the primary treatment choice. Our results will be valuable in overviewing changing patterns of primary treatment in Korean PC patients and planning future health policy for PC.

Citations

Citations to this article as recorded by

Prognosis after radical prostatectomy in men older than 75 years: long-term results from a single tertiary center
Jaewon Lee, Jungkeun Song, Gyoohwan Jung, Sang Hun Song, Sung Kyu Hong
Prostate International.2024; 12(1): 15. CrossRef
Is There a Difference in the Incidence of Depression between Radiation and Surgical Treatments in Patients with Prostate Cancer?
Bum Sik Tae, Sun Tae Ahn, Jung Wan Yoo, Min Sung Song, Hoon Choi, Jae Hyun Bae, Jae Young Park
The World Journal of Men's Health.2024; 42(1): 237. CrossRef
Analysis of trend in the role of national and regional hubs in prostatectomy after prostate cancer diagnosis in the past 5 years: A nationwide population-based study
Seong Cheol Kim, Seungbong Han, Ji Hyung Yoon, Sungchan Park, Kyung Hyun Moon, Sang Hyeon Cheon, Gyung-Min Park, Taekmin Kwon
Investigative and Clinical Urology.2024; 65(2): 124. CrossRef
Current treatment patterns within 1 year after prostate cancer diagnosis in Korean patients over 75 years old: a retrospective multicenter study
Dong Jin Park, Ho Won Kang, Se Yun Kwon, Young Jin Seo, Kyung Seop Lee, Byung Hoon Kim, Teak Jun Shin, Won Tae Kim, Yong-June Kim, Seok Joong Yun, Sang-Cheol Lee, Jae-Wook Chung, Seock Hwan Choi, Jun Nyung Lee, Hyun Tae Kim, Tae-Hwan Kim, Eun Sang Yoo, Ta
Prostate International.2023; 11(1): 34. CrossRef
A Nationwide Study of Differences in Surgical Treatment Rates and Oncological Outcomes for Prostate Cancer according to Economic Status and Region
Sangjun Yoo, Sohee Oh, Min Chul Cho, Hwancheol Son, Hyeon Jeong
Cancer Research and Treatment.2023; 55(2): 652. CrossRef
Outcomes of prostate cancer patients after robot-assisted radical prostatectomy compared with open radical prostatectomy in Korea
Jaehun Jung, Gi Hwan Bae, Jae Heon Kim, Jaehong Kim
Scientific Reports.2023;[Epub] CrossRef
The Incidence of Prostate-Specific Antigen Test in a Country With a Limited Social Perception of Prostate Cancer 2006-2016: Disparities Manifested by Residential Area
Young Hwii Ko, Byung Hoon Kim
The Korean Journal of Urological Oncology.2022; 20(1): 43. CrossRef
Conditional Relative Survival and Competing Mortality of Patients with Prostate Cancer in Korea: A Nationwide Cohort Study
Jinsung Park, Kyungdo Han, Dong Wook Shin, Sang Hyun Park, Hyun Bin Shin
Cancer Epidemiology, Biomarkers & Prevention.2021; 30(2): 326. CrossRef
Epidemiology and genomics of prostate cancer in Asian men
Yao Zhu, Miao Mo, Yu Wei, Junlong Wu, Jian Pan, Stephen J. Freedland, Ying Zheng, Dingwei Ye
Nature Reviews Urology.2021; 18(5): 282. CrossRef
Influence of repeated prostate-specific antigen screening on treatment pattern in a country with a limited social perception of prostate cancer: Korean national wide observational study
Young Hwii Ko, Sang Won Kim
Investigative and Clinical Urology.2021; 62(3): 282. CrossRef
Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality
Hye Yeon Koo, Su-Min Jeong, Mi Hee Cho, Sohyun Chun, Dong Wook Shin, Jinsung Park
Scientific Reports.2021;[Epub] CrossRef
Changes in Patterns of Radical Prostatectomy due to Diffusion of Robotic Surgical System: A Nationwide Study Using Health Insurance Claims Data
Jungmi Chae, Yeonmi Choi, Su-Jin Cho
Yonsei Medical Journal.2021; 62(12): 1155. CrossRef
Combined androgen blockade (CAB) versus luteinizing hormone-releasing hormone (LHRH) agonist monotherapy for androgen deprivation therapy
Hyun Sik Park, Hyun Bin Shin, Seung Hyo Woo, Seung Hyun Jeon, Sang Hyub Lee, Seok Ho Kang, Ji Sung Shim, Dong Wook Shin, Jinsung Park
World Journal of Urology.2020; 38(4): 971. CrossRef
Variation in radiotherapy patterns of care in the radical treatment of South Australian men with non-metastatic prostate cancer between 2005–2015
Stamati Morias, Elizabeth Buckley, Kerri Beckmann, Michael O'Callaghan, Martin Borg, Michala Short
Radiotherapy and Oncology.2020; 145: 138. CrossRef
Single-port robot-assisted radical prostatectomy with the da Vinci SP system: A single surgeon's experience
Kwang Hyun Kim, Wan Song, Hana Yoon, Dong Hyeon Lee
Investigative and Clinical Urology.2020; 61(2): 173. CrossRef
Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea
Jihun Kang, Dong Wook Shin, Kyungdo Han, Sang Hyun Park, Won Gu Lee, Jung Eun Yoo, Seung-Hyo Woo, Jinsung Park
Current Problems in Cancer.2020; 44(6): 100578. CrossRef
Risk of Ischemic Heart Disease and Stroke in Prostate Cancer Survivors: A Nationwide Study in South Korea
Dong Wook Shin, Kyungdo Han, Hyun Sik Park, Seung-Pyo Lee, Sang Hyun Park, Jinsung Park
Scientific Reports.2020;[Epub] CrossRef
Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study
Dong Wook Shin, Sang Hyub Lee, Tae-Hwan Kim, Seok Joong Yun, Jong Kil Nam, Seung Hyun Jeon, Seung Chol Park, Seung Il Jung, Jong-Hyock Park, Jinsung Park
Cancer Research and Treatment.2019; 51(2): 556. CrossRef
Medical Travel among Non-Seoul Residents to Seek Prostate Cancer Treatment in Medical Facilities of Seoul
Jae Heon Kim, So Young Kim, Seok-Joong Yun, Jae Il Chung, Hoon Choi, Ho Song Yu, Yun-Sok Ha, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Wun-Jae Kim, Jong-Hyock Park, Ji Youl Lee
Cancer Research and Treatment.2019; 51(1): 53. CrossRef
Trends in Prostate Cancer Prevalence and Radical Prostatectomy Rate according to Age Structural Changes in South Korea between 2005 and 2015
Hyun Young Lee, Suyeon Park, Seung Whan Doo, Won Jae Yang, Yun Seob Song, Jae Heon Kim
Yonsei Medical Journal.2019; 60(3): 257. CrossRef
Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence
Paramita Dasgupta, Peter D. Baade, Joanne F. Aitken, Nicholas Ralph, Suzanne Kathleen Chambers, Jeff Dunn
Frontiers in Oncology.2019;[Epub] CrossRef
National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database
Ho Won Kang, Seok-Joong Yun, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, Yun-Sok Ha, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Wun-Jae Kim, Jong-Hyock Park, Ji Youl Lee, So-Young Kim
BMC Health Services Research.2019;[Epub] CrossRef
Prognostic significance of lymphovascular invasion in patients with prostate cancer treated with postoperative radiotherapy
Jae-Uk Jeong, Taek-Keun Nam, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung, Ick Joon Cho, Yong-Hyub Kim, Shin Haeng Cho, Seung Il Jung, Dong Deuk Kwon
Radiation Oncology Journal.2019; 37(3): 215. CrossRef
Radiotherapy in prostate cancer treatment: results of the patterns of care study in Korea
Ah Ram Chang, Won Park
Radiation Oncology Journal.2017; 35(1): 25. CrossRef
Cause of Death in Korean Men with Prostate Cancer: an Analysis of Time Trends in a Nationwide Cohort
Jinsung Park, Beomseok Suh, Dong Wook Shin, Jun Hyuk Hong, Hanjong Ahn
Journal of Korean Medical Science.2016; 31(11): 1802. CrossRef

11,658 View
223 Download
26 Web of Science
25 Crossref

Terminal Versus Advanced Cancer: Do the General Population and Health Care Professionals Share a Common Language?: Sang Hyuck Kim, Dong Wook Shin, So Young Kim, Hyung Kook Yang, Eunjoo Nam, Hyun Jung Jho, Eunmi Ahn, Be Long Cho, Keeho Park, Jong-Hyock Park; Cancer Res Treat. 2016;48(2):759-767. Published online August 10, 2015; DOI: https://doi.org/10.4143/crt.2015.124

Abstract PDF PubReader ePub

Purpose
Many end-of-life care studies are based on the assumption that there is a shared definition of language concerning the stage of cancer. However, studies suggest that patients and their families often misperceive patients’ cancer stages and prognoses. Discrimination between advanced cancer and terminal cancer is important because the treatment goals are different. In this study, we evaluated the understanding of the definition of advanced versus terminal cancer of the general population and determined associated socio-demographic factors. Materials and Methods A total of 2,000 persons from the general population were systematically recruited. We used a clinical vignette of a hypothetical advanced breast cancer patient, but whose cancer was not considered terminal. After presenting the brief history of the case, we asked respondents to choose the correct cancer stage from a choice of early, advanced, terminal stage, and don’t know. Multinomial logistic regression analysis was performed to determine sociodemographic factors associated with the correct response, as defined in terms of medical context.
Results
Only 411 respondents (20.6%) chose “advanced,“ while most respondents (74.5%) chose “terminal stage” as the stage of the hypothetical patient, and a small proportion of respondents chose “early stage” (0.7%) or “don’t know” (4.4%). Multinomial logistic regression analysis found no consistent or strong predictor.
Conclusion
A large proportion of the general population could not differentiate advanced cancer from terminal cancer. Continuous effort is required in order to establish common and shared definitions of the different cancer stages and to increase understanding of cancer staging for the general population.

Citations

Citations to this article as recorded by

A qualitative study on redefining normality in relatives of patients with advanced cancer
Helen P. A. Driessen, Evi M. Bakker, Judith A. C. Rietjens, Khanh L. N. Luu, Marjolein Lugtenberg, Frederika E. Witkamp, Leonieke W. Kranenburg
Cancer Medicine.2024;[Epub] CrossRef
Prediction of prognosis in lung cancer using machine learning with inter-institutional generalizability: A multicenter cohort study (WJOG15121L: REAL-WIND)
Daichi Fujimoto, Hidetoshi Hayashi, Kenta Murotani, Yukihiro Toi, Toshihide Yokoyama, Terufumi Kato, Teppei Yamaguchi, Kaoru Tanaka, Satoru Miura, Motohiro Tamiya, Motoko Tachihara, Takehito Shukuya, Yuko Tsuchiya-Kawano, Yuki Sato, Satoshi Ikeda, Shinya
Lung Cancer.2024; 194: 107896. CrossRef
Preserving the integrity of personhood in people with advanced cancer: An in-depth qualitative study among patients, relatives, and care professionals
Alina Senßfelder, Matthias Havemann, Anna J Pedrosa Carrasco, Pia von Blanckenburg, Carola Seifart
Palliative Medicine.2024; 38(9): 1054. CrossRef
Complementary Musical Intervention for Patients in Palliative Care in Spain: A Randomized Controlled Trial
Inmaculada Valero-Cantero, María Ángeles Vázquez-Sánchez, José Luis Casals-Sánchez, Milagrosa Espinar-Toledo, Juan Corral-Pérez, Cristina Casals
Healthcare.2024; 12(19): 1938. CrossRef
Challenges of Home Parenteral Nutrition for Patients with Advanced Cancer
Soroor Fathi, Bahareh Aminnejad kavkani, Soheila Shekari, Samaneh Mirzaei Dahka, Naeemeh Hassanpour Ardekanizadeh, Golsa Khalatbari Mohseni, Maryam Gholamalizadeh, Kourosh Delpasand, Nasibe Jafarnia, Fatemeh Mohammadi-Nasrabadi, Saeid Doaei
International Journal of Cancer Management.2023;[Epub] CrossRef
Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and Solutions
Olena Mandrik, Chloe Thomas, Sophie Whyte, James Chilcott
PharmacoEconomics.2022; 40(4): 359. CrossRef
End-of-life communication experiences within families of people with advanced cancer in China: A qualitative study
Tianmeng Xu, Yuan Qin, Xiaohong Ou, Xiaowei Zhao, Pei Wang, Mengmeng Wang, Peng Yue
International Journal of Nursing Studies.2022; 132: 104261. CrossRef
Shock Index Is a Validated Prediction Tool for the Short-Term Survival of Advanced Cancer Patients Presenting to the Emergency Department
Zhong Ning Leonard Goh, Mu-Wei Chen, Hao-Tsai Cheng, Kuang-Hung Hsu, Chen-Ken Seak, Joanna Chen-Yeen Seak, Seng Kit Ling, Shao-Feng Liao, Tzu-Heng Cheng, Yi-Da Sie, Chih-Huang Li, Hsien-Yi Chen, Cheng-Yu Chien, Chen-June Seak
Journal of Personalized Medicine.2022; 12(6): 954. CrossRef
Challenges in self‐management of persons living with advanced cancer: An exploratory, in‐depth interview study
Hanna Noorlandt, Rik Stoevelaar, Sophie van Dongen, Muzeyyen Arslan, Nancy Luu, Leonieke Kranenburg, Erica Witkamp, Carin van der Rijt, Kate Lorig, Agnes van der Heide, Judith Rietjens
European Journal of Cancer Care.2022;[Epub] CrossRef
A qualitative meta-synthesis examining spirituality as experienced by individuals living with terminal cancer
Lucy Hayden, Emma Byrne, Avril Deegan, Simon Dunne, Pamela Gallagher
Health Psychology Open.2022;[Epub] CrossRef
Home Parenteral Nutrition in Patients with Advanced Cancer: A Systematic Review and Meta-Analysis
Francis J. O’Hanlon, Konstantinos C. Fragkos, Lucia Fini, Pinal S. Patel, Shameer J. Mehta, Farooq Rahman, Simona Di Caro
Nutrition and Cancer.2021; 73(6): 943. CrossRef
Strategies for living well with hormone-responsive advanced prostate cancer—a qualitative exploration
Lauren Matheson, Jo Nayoan, Carol Rivas, Jo Brett, Penny Wright, Hugh Butcher, Paul Jordan, Anna Gavin, Adam Glaser, Malcolm Mason, Richard Wagland, Eila Watson
Supportive Care in Cancer.2021; 29(3): 1317. CrossRef
Cancer treatment resumption in patients with new-generation drug-eluting stents
Dinu Valentin Balanescu, Moez Karim Aziz, Teodora Donisan, Nicolas Palaskas, Juan Lopez-Mattei, Saamir Hassan, Peter Kim, Juhee Song, William Ntim, Mehmet Cilingiroglu, Konstantinos Marmagkiolis, Cezar Iliescu
Coronary Artery Disease.2021; 32(4): 295. CrossRef
Physical Activity for Individuals Living with Advanced Cancer: Evidence and Recommendations
Lauren C. Capozzi, Julia T. Daun, Manuel Ester, Stephen Mosca, David Langelier, George J. Francis, Eugene Chang, Daniel Santa Mina, Jack B. Fu, S. Nicole Culos-Reed
Seminars in Oncology Nursing.2021; 37(4): 151170. CrossRef
Shock Index: A Simple and Effective Clinical Adjunct in Predicting 60-Day Mortality in Advanced Cancer Patients at the Emergency Department
Tzu-Heng Cheng, Yi-Da Sie, Kuang-Hung Hsu, Zhong Ning Leonard Goh, Cheng-Yu Chien, Hsien-Yi Chen, Chip-Jin Ng, Chih-Huang Li, Joanna Chen-Yeen Seak, Chen-Ken Seak, Yi-Tung Liu, Chen-June Seak
International Journal of Environmental Research and Public Health.2020; 17(13): 4904. CrossRef
Impact of prognostic nutritional index on terminal cancer patients
AmrallahA Mohammed, Omar Al-Zahrani, FifiMostafa Elsayed
Indian Journal of Palliative Care.2020; 26(4): 433. CrossRef
Metastatic Breast Cancer as a Chronic Condition
Patti Rager Zuzelo
Holistic Nursing Practice.2019; 33(2): 125. CrossRef
Experiences and Opinions Related to End-of-Life Discussion: From Oncologists' and Resident Physicians' Perspectives
Su-Jin Koh, Shinmi Kim, JinShil Kim, Bhumsuk Keam, Dae Seog Heo, Kyung Hee Lee, Bong-Seog Kim, Jee Hyun Kim, Hye Jung Chang, Sun Kyung Baek
Cancer Research and Treatment.2018; 50(2): 614. CrossRef
End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer
Yingming Zhu, Ke Tang, Fen Zhao, Yuanwei Zang, Xiaodong Wang, Zhenxiang Li, Xindong Sun, Jinming Yu
Journal of Cancer Research and Clinical Oncology.2018; 144(8): 1591. CrossRef
Consensus guidelines for the definition of the end stage of disease and last days of life and criteria for medical judgment
Sang-Min Lee, Su-Jung Kim, Youn Seon Choi, Dae Seog Heo, Sujin Baik, Bo Moon Choi, Daekyun Kim, Jae Young Moon, So Young Park, Yoon Jung Chang, In Cheol Hwang, Jung Hye Kwon, Sun-Hyun Kim, Yu Jung Kim, Jeanno Park, Ho Jung Ahn, Hyun Woo Lee, Ivo Kwon, Do-
Journal of the Korean Medical Association.2018; 61(8): 509. CrossRef
A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea
Ralph J. Johnson
BMC Psychiatry.2018;[Epub] CrossRef
Comment on “Asian collaboration to establish a provisional system to provide high‐quality end‐of‐life care by promoting advance care planning for the elderly”
Dong Wook Shin, Ji Eun Lee, BeLong Cho, Sang Ho Yoo, SangYun Kim, Jun‐Hyun Yoo
Geriatrics & Gerontology International.2017; 17(4): 672. CrossRef

12,933 View
102 Download
24 Web of Science
22 Crossref

Public Perceptions on Cancer Incidence and Survival: A Nation-wide Survey in Korea: Soyeun Kim, Dong Wook Shin, Hyung Kook Yang, So Young Kim, Young-Jin Ko, BeLong Cho, Young Sung Lee, Dukhyoung Lee, Keeho Park, Jong Hyock Park; Cancer Res Treat. 2016;48(2):775-788. Published online May 26, 2015; DOI: https://doi.org/10.4143/crt.2014.369

Abstract PDF PubReader ePub

Purpose
The aim of this study was to compare the public perceptions of the incidence rates and survival rates for common cancers with the actual rates from epidemiologic data.
Materials and Methods
We conducted a survey of Korean adults without history of cancer (n=2,000). The survey consisted of questions about their perceptions regarding lifetime incidence rates and 5-year survival rates for total cancer, as well as those of eight site-specific cancers. To investigate associated factors, we included questions about cancer worry (Lerman’s Cancer Worry Scale) or cared for a family member or friend with cancer as a caregiver.
Results
Only 19% of Korean adults had an accurate perception of incidence rates compared with the epidemiologic data on total cancer. For specific cancers, most of the respondents overestimated the incidence rates and 10%-30% of men and 6%-18% of women had an accurate perception. A high score in “cancer worry” was associated with higher estimates of incidence rates in total and specific cancers. In cancers with high actual 5-year survival rates (e.g., breast and thyroid), the majority of respondents underestimated survival rates. However, about 50% of respondents overestimated survival rates in cancers with low actual survival rates (e.g., lung and liver). There was no factor consistently associated with perceived survival rates.
Conclusion
Widespread discrepancies were observed between perceived probability and actual epidemiological data. In order to reduce cancer worry and to increase health literacy, communication and patient education on appropriate risk is needed.

Citations

Citations to this article as recorded by

The correlation between individuals’ attitudes toward cancer screening, cancer information overload, and healthy life awareness: a cross-sectional study
Melike Demir Doğan, Seda Kurt, Berkay Ertin
Journal of Public Health.2024; 32(5): 759. CrossRef
Assessing Fear of Thyroid Cancer in the General U.S. Population: A Cross-Sectional Study
Stephanie R. Taylor, Alexander Chiu, Ines Hoxha, Megan C. Saucke, Catherine B. Jensen, Susan C. Pitt
Thyroid®.2024; 34(2): 234. CrossRef
Chasm between Public Perceptions and Epidemiological Data on Colorectal Cancer
Su Bee Park, Min Seob Kwak, Jin Young Yoon, Jae Myung Cha
Gut and Liver.2023; 17(3): 449. CrossRef
A Web-Based Decision Aid for Informed Prostate Cancer Screening: Development and Pilot Evaluation
Wonyoung Jung, In Young Cho, Keun Hye Jeon, Yohwan Yeo, Jae Kwan Jun, Mina Suh, Ansuk Jeong, Jungkwon Lee, Dong Wook Shin
Journal of Korean Medical Science.2023;[Epub] CrossRef
Barriers and Challenges to Cervical Cancer Screening, Follow.Up, and Prevention Measures among Korean Immigrant Women in Hawaii
Eurina Y Cha, Hans Chun
Asia-Pacific Journal of Oncology Nursing.2021; 8(2): 132. CrossRef
Health-Related Quality of Life, Perceived Social Support, and Depression in Disease-Free Survivors Who Underwent Curative Surgery Only for Prostate, Kidney and Bladder Cancer: Comparison among Survivors and with the General Population
Dong Wook Shin, Hyun Sik Park, Sang Hyub Lee, Seung Hyun Jeon, Seok Cho, Seok Ho Kang, Seung Chol Park, Jong Hyock Park, Jinsung Park
Cancer Research and Treatment.2019; 51(1): 289. CrossRef
Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study
Dong Wook Shin, Sang Hyub Lee, Tae-Hwan Kim, Seok Joong Yun, Jong Kil Nam, Seung Hyun Jeon, Seung Chol Park, Seung Il Jung, Jong-Hyock Park, Jinsung Park
Cancer Research and Treatment.2019; 51(2): 556. CrossRef
A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial
Sung Yong Oh, Won Seog Kim, Jin Seok Kim, Yee Soo Chae, Gyeong-Won Lee, Hyeon Seok Eom, Hun Mo Ryoo, Suee Lee, Seok Jin Kim, Dok Hyun Yoon, Jong Ho Won, Junshik Hong, Jinny Park, Sang-Min Lee, Jung Yong Hong, Eunkyung Park, Hyo Jung Kim, Deok-Hwan Yang, H
Leukemia & Lymphoma.2016; 57(6): 1406. CrossRef
News Portrayal of Cancer: Content Analysis of Threat and Efficacy by Cancer Type and Comparison with Incidence and Mortality in Korea
Minsun Shim, Yong-Chan Kim, Su Yeon Kye, Keeho Park
Journal of Korean Medical Science.2016; 31(8): 1231. CrossRef
The Workplace Experiences of Breast Cancer Survivors: A Survey of an Online Community
Ka Ryeong Bae, Sun Young Kwon
Asian Oncology Nursing.2016; 16(4): 208. CrossRef

12,855 View
130 Download
11 Web of Science
10 Crossref

Family Avoidance of Communication about Cancer: A Dyadic Examination: Dong Wook Shin, Jooyeon Shin, So Young Kim, Hyung-Kook Yang, Juhee Cho, Jung Ho Youm, Gyu Seog Choi, Nam Soo Hong, BeLong Cho, Jong-Hyock Park; Cancer Res Treat. 2016;48(1):384-392. Published online March 13, 2015; DOI: https://doi.org/10.4143/crt.2014.280

Abstract PDF PubReader ePub

Purpose
This study aimed to examine the following questions: to what extent do patients and caregivers perceive their family members to be avoidant of communication regarding patient’s cancer, and to what extent do these perceptions interrelate; and how do such perceptions influence their own and each other’s communication behaviors, communication outcome, mental health, and quality of life. Materials and Methods A national survey was performed with 990 patient-caregiver dyads (participation rate, 76.2%). To examine the dyadic interaction, we developed linked patient and family member questionnaires, including the Family Avoidance of Communication about Cancer (FACC) scale. Results The mean scores (standard deviations) of patient- and caregiver-perceived FACC were low at 10.9 (15.5) and 15.5 (17.5), respectively (p < 0.001), and concordance was low, a well (Spearman’s rho, 0.23). Patient-perceived FACC was associated with lower levels of disclosure and behaviors of holding back communication, as well as lower levels of mental health outcome and quality of life. The same was true for caregivers (all p < 0.05). Patient-perceived FACC was associated with caregiver holding back, caregiver’s depression level, and caregiver quality of life (all p < 0.05). Both patient- and caregiver-perceived FACC were independently associated with communication difficulty within the family. Conclusion Future research would benefit from the measurement of FACC from both patients and caregivers, and promote family intervention to enhance openness to communication, which would be helpful for improving mental health and quality of life for both patients and caregivers.

Citations

Citations to this article as recorded by

Dyadic association between mindfulness, family avoidance of communication about cancer and fear of cancer recurrence among breast cancer couples: A cross-sectional study
Xiangyu Zhao, Yunxue Zhang, Rui Qin, Guopeng Li, Xudong He, Xiaona Shen, Ping Li
European Journal of Oncology Nursing.2024; 68: 102491. CrossRef
Caring for a Parent With a Blood Cancer: Sibling Communication Challenges and Psychosocial Outcomes
Kevin B. Wright, Carma L. Bylund, Diliara Bagautdinova, Chelsea N. Hampton, Gemme Campbell-Salome, Elisa S. Weiss, Maria Sae-Hau, Carla L. Fisher
Families in Society: The Journal of Contemporary Social Services.2024;[Epub] CrossRef
Understanding the patient-spouse communication experience during chemotherapy for gastric cancer: A qualitative study
Ye Zhou, Chong Chin Che, Mei Chan Chong, Yuzhu Hou, Xiangqun Xiao, Yun Liu, Haiyan Zhao
Journal of Psychosocial Oncology.2024; : 1. CrossRef
Cancer Caregivers’ Prognostic and End-of-Life Communication Needs and Experiences and their Impact
Anny T.H.R. Fenton, Kalen M. Fletcher, Deniz Kizildag, Nancy A. Borstelmann, Daniela Kessler, Christine Cronin, Anna C. Revette, Alexi A. Wright, Elizabeth Frank, Andrea C. Enzinger
Journal of Pain and Symptom Management.2023; 65(1): 16. CrossRef
Relationships Among Perceived Social Support, Family Resilience, and Caregiver Burden in Lung Cancer Families: A Mediating Model
Yalin Zhang, Yuxin Ding, Chunhua Liu, Juejin Li, Qi Wang, Yunhuan Li, Xiaolin Hu
Seminars in Oncology Nursing.2023; 39(3): 151356. CrossRef
Exploring Dyad-Based Communication During Cancer
Martha E. Francis, Pranshu Mohindra, Kim Mooney-Doyle
Cancer Nursing.2023; 46(6): E384. CrossRef
Contributors to well‐being of Chinese left‐behind families: A dyadic perspective from family resilience and grandparent–grandchild relationship
Qiong Hu, Yanlin Zhou, Peiqi Dong, Cihua Xu, Qiong Zhang
Child & Family Social Work.2023; 28(3): 646. CrossRef
The perception of life and death in patients with end-of-life stage cancer: A systematic review of qualitative research
Ayumi Kyota, Kiyoko Kanda, Maiko Senuma, Noriko Tsukagoshi, Tamae Futawatari, Yuka Kondo
European Journal of Oncology Nursing.2023; 66: 102354. CrossRef
Communication with cancer patients: the perspective of caregivers versus non-caregivers in Iran
Azam Naghavi, Samaneh Salimi, Winfried Rief, Pia von Blanckenburg
Frontiers in Psychology.2023;[Epub] CrossRef
Caregiver burden among family caregivers of patients with advanced cancer in a palliative context: A mixed‐method study
Yalin Zhang, Shu Zhang, Chunhua Liu, Xiaoli Chen, Yuxin Ding, Chang Guan, Xiaolin Hu
Journal of Clinical Nursing.2023; 32(21-22): 7751. CrossRef
Distinct dyadic quality of life profiles among patient-caregiver dyads with advanced lung cancer: a latent profile analysis
Hui Wang, Tiantian Deng, Cong Cao, Danjun Feng
Supportive Care in Cancer.2023;[Epub] CrossRef
Family communication and coping among racial‐ethnic minority cancer patients: A systematic review
Yu‐Ju Huang, Chiara Acquati, Monit Cheung
Health & Social Care in the Community.2022;[Epub] CrossRef
Barriers to seeking psychosocial support among adult patients with hematologic neoplasms: a qualitative study
Mengting Xie, Chunfeng Wang, Jingyi Chen, Ying Wang, Xiaoxia Wu, Yong Wu, Rong Hu
Supportive Care in Cancer.2022; 30(3): 2613. CrossRef
Openness and topic avoidance in interpersonal communication about ovarian cancer: An uncertainty management perspective
Dinah A. Tetteh, Najma Akhther
Qualitative Research in Medicine and Healthcare.2022;[Epub] CrossRef
Patient-caregiver communication concordance in cancer—refinement of the Cancer Communication Assessment Tool in an Australian sample
Natasha Michael, Alex Gorelik, Ekavi Georgousopoulou, Merlina Sulistio, Patrick Tee, Katherine Hauser, David Kissane
Supportive Care in Cancer.2022; 30(9): 7387. CrossRef
The role of caregivers in the clinical pathway of patients newly diagnosed with breast and prostate cancer: A study protocol
Clizia Cincidda, Serena Oliveri, Virginia Sanchini, Gabriella Pravettoni
Frontiers in Psychology.2022;[Epub] CrossRef
Efficacy of a dyadic intervention to improve communication between patients with cancer and their caregivers: A randomized pilot trial
Julien Tiete, Nicole Delvaux, Aurore Liénard, Darius Razavi
Patient Education and Counseling.2021; 104(3): 563. CrossRef
Hostility in cancer patients as an underexplored facet of distress
Luigi Grassi, Martino Belvederi Murri, Michelle Riba, Silvia de Padova, Tatiana Bertelli, Silvana Sabato, Maria Giulia Nanni, Rosangela Caruso, Heifa Ounalli, Luigi Zerbinati
Psycho-Oncology.2021; 30(4): 493. CrossRef
Effects of family participatory dignity therapy on the psychological well-being and family function of patients with haematologic malignancies and their family caregivers: A randomised controlled trial
Chunfeng Wang, Jingyi Chen, Ying Wang, Wenkui Xu, Mengting Xie, Yong Wu, Rong Hu
International Journal of Nursing Studies.2021; 118: 103922. CrossRef
The effect of death anxiety in nurses on their approach to dying patients: A cross‐sectional study
Adalet Üstükuş, Zehra Eskimez
Perspectives in Psychiatric Care.2021; 57(4): 1929. CrossRef
Dyadic effects of family-functioning and resilience on quality of life in advanced lung cancer patients and caregivers: An actor-partner interdependence mediation model
Hui Wang, Haorun Yue, Minmin Ren, Danjun Feng
European Journal of Oncology Nursing.2021; 52: 101963. CrossRef
Multiple approaches to enhancing cancer communication in the next decade: translating research into practice and policy
Claire C Conley, Amy K Otto, Glynnis A McDonnell, Kenneth P Tercyak
Translational Behavioral Medicine.2021; 11(11): 2018. CrossRef
The Dyadic Cancer Outcomes Framework: A general framework of the effects of cancer on patients and informal caregivers
Tess Thompson, Dana Ketcher, Tamryn F. Gray, Erin E. Kent
Social Science & Medicine.2021; 287: 114357. CrossRef
The Self-Efficacy to Communicate about Sex and Intimacy (SECSI) scale: psychometric assessment in women treated for cancer
Elizabeth K. Arthur, Celia E. Wills, Kristine Browning, Janine Overcash, Usha Menon
Supportive Care in Cancer.2020; 28(3): 1449. CrossRef
The Critical Need to Recognize That Families Matter for Adult Health: A Systematic Review of the Literature
Sarah B. Woods, Kate Bridges, Erica N. Carpenter
Family Process.2020; 59(4): 1608. CrossRef
Family Communication Patterns and Challenges of Huntington’s Disease Risk, the Decision to Pursue Presymptomatic Testing, and Test Results
Kelsey Stuttgen, Juli Bollinger, Allison McCague, Rachel Dvoskin, Debra Mathews
Journal of Huntington's Disease.2020; 9(3): 265. CrossRef
Open communication between caregivers’ and terminally ill cancer patients about illness and death: The role of gender - A correlational study
Sara Carmel, Yoram Singer, Nili Yosef-Sela, Yaacov G. Bachner
European Journal of Oncology Nursing.2020; 49: 101828. CrossRef
Patient-family communication mediates the relation between family hardiness and caregiver positivity: Exploring the moderating role of caregiver depression and anxiety
Joo Yeon Shin, Michael F. Steger, Dong Wook Shin, So Young Kim, Hyung-Kook Yang, Juhee Cho, Ansuk Jeong, Keeho Park, Sun Seog Kweon, Jong-Hyock Park
Journal of Psychosocial Oncology.2019; 37(5): 557. CrossRef
Reports of Sharing and Withholding Cancer-Related Information by Patients With Gynecologic Cancer and Their Supporters
Maria Checton, Maria Venetis, Danielle Catona, Allyson Bontempo, Kathryn Greene, Alexandre de Meritens, Katie Devine
Oncology Nursing Forum.2019; 46(6): 676. CrossRef
Family Members’ Experiences With Dialysis and Kidney Transplantation
Nicole DePasquale, Ashley Cabacungan, Patti L. Ephraim, LaPricia Lewis-Boyér, Neil R. Powe, L. Ebony Boulware
Kidney Medicine.2019; 1(4): 171. CrossRef
The relationship between holding back from communicating about breast concerns and anxiety in the year following breast biopsy
Caroline S. Dorfman, Eneka Lamb, Alyssa Van Denburg, Anava A. Wren, Mary Scott Soo, Kaylee Faircloth, Vicky Gandhi, Rebecca A. Shelby
Journal of Psychosocial Oncology.2018; 36(2): 222. CrossRef
Underestimated caregiver burden by cancer patients and its association with quality of life, depression and anxiety among caregivers
J.Y. Shin, J.-W. Lim, D.W. Shin, S.Y. Kim, H.-K. Yang, J. Cho, A. Jeong, D. Jo, C.-Y. Yim, K. Park, J.-H. Park
European Journal of Cancer Care.2018; 27(2): e12814. CrossRef
The Dyadic Effects of Family Cohesion and Communication on Health-Related Quality of Life: The Moderating Role of Sex
Jung-won Lim, En-jung Shon
Cancer Nursing.2018; 41(2): 156. CrossRef

12,513 View
134 Download
34 Web of Science
33 Crossref

Medical Costs and Healthcare Utilization among Cancer Decedents in the Last Year of Life in 2009: Inuk Hwang, Dong Wook Shin, Kyoung Hee Kang, Hyung Kook Yang, So Young Kim, Jong-Hyock Park; Cancer Res Treat. 2016;48(1):365-375. Published online March 2, 2015; DOI: https://doi.org/10.4143/crt.2014.088

Abstract PDF PubReader ePub

Purpose
The purpose of this study was to evaluate the cancer care cost during the last year of life of patients in Korea. Materials and Methods We studied the breakdown of spending on the components of cancer care. Cancer decedents in 2009 were identified from the Korean Central Cancer Registry and linked with the Korean National Health Insurance Claims Database. The final number of patients included in the study was 70,558.
Results
In 2009, the average cancer care cost during the last year of life was US $15,720. Patients under age 20 spent US $53,890 while those 70 or over spent US $11,801. Those with leukemia incurred the highest costs (US $43,219) while bladder cancer patients spent the least (US $13,155). General costs, drugs other than analgesics, and test fees were relatively high (29.7%, 23.8%, and 20.7% of total medical costs, respectively). Analgesic drugs, rehabilitation, and psychotherapy were still relatively low (4.3%, 0.7%, and 0.1%, respectively). Among the results of multiple regression analysis, few were notable. Age was found to be negatively related to cancer care costs while income level was positively associated. Those classified under distant Surveillance, Epidemiology, and End Results stages of cancer and higher comorbidity level also incurred higher cancer care costs. Conclusion Average cancer care costs varied significantly by patient characteristics. However, the study results suggest an underutilization of support services likely due to lack of alternative accommodations for terminal cancer patients. Further examination of utilization patterns of healthcare resources will help provide tailored evidence for policymakers in efforts to reduce the burdens of cancer care.

Citations

Citations to this article as recorded by

Patterns of Medical Utilization in Children, Adolescents, and Young Adults With Life-Limiting Conditions in Korea: A Cohort Study Based on National Health Insurance Data
Seonhwa Lee, Byungmi Kim, Jin Young Choi, So-Jung Park, Jun Ah Lee, Chung Ho Kim, Bomi Park, Bohyun Park
Journal of Korean Medical Science.2025;[Epub] CrossRef
Medical care costs at the end of life among older adults with cancer: a national health insurance data-based cohort study
Minjeong Jo, Yunji Lee, Taehwa Kim
BMC Palliative Care.2023;[Epub] CrossRef
Medical cost of advanced illnesses in the last-year of life—retrospective database study
Palvinder Kaur, Huei Yaw Wu, Allyn Hum, Bee Hoon Heng, Woan Shin Tan
Age and Ageing.2022;[Epub] CrossRef
Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea
Gyeyoung Choi, Yujeong Kim, Gyeongseon Shin, SeungJin Bae
International Journal of Environmental Research and Public Health.2022; 19(5): 2494. CrossRef
Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care
Kyu-Tae Han, Woorim Kim, Seungju Kim
BMC Cancer.2022;[Epub] CrossRef
Healthcare resource utilization and medical costs in patients with terminal cancer during best supportive care
Dong-Won Kang, Yoon-Bo Shim, Eui-Kyung Lee, Mi-Hai Park, Wen-Chi Chou
PLOS ONE.2022; 17(6): e0269565. CrossRef
Trends in End-of-Life Resource Utilization and Costs among Prostate Cancer Patients from 2006 to 2015: A Nationwide Population-Based Study
Yun-Sok Ha, So-Young Kim, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Ji Youl Lee, Dong Jin Park, Hyun Tae Kim, Eun Sang Yoo, Tae Gyun Kwon, Kyungchan Min, Wun-Jae Kim, Seok Joong Yun, Jo
The World Journal of Men's Health.2021; 39(1): 158. CrossRef
End-of-life cost trajectories and the trade-off between treatment costs and life-extension: Findings from the Cost and Medical Care of Patients with Advanced Serious Illness (COMPASS) cohort study
Brett Doble, Wei Han Melvin Wong, Eric Finkelstein
Palliative Medicine.2021; 35(5): 893. CrossRef
Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study
Audrey Tanguy-Melac, Dorian Verboux, Laurence Pestel, Anne Fagot-Campagna, Philippe Tuppin, Christelle Gastaldi-Ménager
The European Journal of Health Economics.2021; 22(7): 1039. CrossRef
How the resource allocation and inpatient behavior affect the expenditures of terminal malignant tumor patients?
Fen Li, Bifan Zhu, Peimin Sang, Chunlin Jin
Journal of Cancer Policy.2020; 25: 100249. CrossRef
Cost of Care and Pattern of Medical Care Use in the Last Year of Life among Long-Term Care Insurance Beneficiaries in South Korea: Using National Claims Data
Sunjoo Boo, Jungah Lee, Hyunjin Oh
International Journal of Environmental Research and Public Health.2020; 17(23): 9078. CrossRef
The Last Year Before Graft Failure Negatively Impacts Economic Outcomes and is Associated With Greater Healthcare Resource Utilization Compared With Previous Years in the United Kingdom: Results of a Retrospective Observational Study
Gorden Muduma, Varuna Aluvihare, Marc Clancy, Enrico de Nigris, Carolyn Whitlock, Margarita Landeira, Jameel Nazir
Transplantation Direct.2019; 5(5): e443. CrossRef
National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database
Ho Won Kang, Seok-Joong Yun, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, Yun-Sok Ha, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Wun-Jae Kim, Jong-Hyock Park, Ji Youl Lee, So-Young Kim
BMC Health Services Research.2019;[Epub] CrossRef
Budget impact analysis of gene expression tests to aid therapy decisions for breast cancer patients in Germany
M.P. Lux, N. Nabieva, T. Hildebrandt, H. Rebscher, S. Kümmel, J.-U. Blohmer, M.G. Schrauder
The Breast.2018; 37: 89. CrossRef
Intensity of Care at the End of Life Among Older Adults in Korea
Su Hyun Kim, Sangwook Kang, Mi-Kyung Song
Journal of Palliative Care.2018; 33(1): 47. CrossRef
Gasto en el último año de vida para pacientes que mueren con cáncer
Sergio I. Prada, Juan F. Contreras
Revista Colombiana de Cancerología.2018; 22(1): 3. CrossRef
Medical care costs of cancer in the last year of life using national health insurance data in Korea
Mihai Park, Inmyung Song, M Barton Laws
PLOS ONE.2018; 13(6): e0197891. CrossRef
The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer
Shin Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
Cancer Research and Treatment.2018; 50(3): 720. CrossRef
Evaluation of the Cost of Comprehensive Outpatient Therapies in Patients with Malignant Brain Tumors
Stacy McCarty, Susan Keeshin, Sarah M. Eickmeyer, Samman Shahpar, Patrick Semik, Alex W. K. Wong
American Journal of Physical Medicine & Rehabilitation.2017; 96(5): 341. CrossRef
Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada
Ahmed S. Zakaria, Fabiano Santos, Alice Dragomir, Wassim Kassouf, Simon Tanguay, Armen Aprikian
Urologic Oncology: Seminars and Original Investigations.2017; 35(9): 539.e1. CrossRef
Joint Symposium of Korean Cancer Association & UICC-ARO—Cross-boundary cancer studies: cancer and Universal Health Coverage (UHC) in Asia
Eun-Cheol Park, Norie Kawahara, Shinjiro Nozaki, Hasbullah Thabrany, Shunya Yoshimi, Sohee Park, Duk Hyoung Lee, Hideyuki Akaza, Jae Kyung Roh
Japanese Journal of Clinical Oncology.2017; 47(9): 889. CrossRef
Escalating Health Care Expenditures in Cancer Decedents’ Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan
Yen-Ni Hung, Tsang-Wu Liu, Fur-Hsing Wen, Wen-Chi Chou, Siew Tzuh Tang
The Oncologist.2017; 22(4): 460. CrossRef

11,532 View
122 Download
26 Web of Science
22 Crossref

Oncologists’ Experience with Patients with Second Primary Cancer and the Attitudes toward Second Primary Cancer Screening: A Nationwide Survey: Dong Wook Shin, Juhee Cho, Hyung Kook Yang, So Young Kim, Boram Park, BeLong Cho, Hyung Jin Kim, Young Jun Lee, Deog-Yeon Jo, Jong Hyock Park; Cancer Res Treat. 2015;47(4):600-606. Published online February 12, 2015; DOI: https://doi.org/10.4143/crt.2014.162

Abstract PDF PubReader ePub

Purpose
Screening for second primary cancer (SPC) is one of the key components to survivorship care. We aim to evaluate the oncologists’ experience with SPCs and assess the current practice, perceived barriers, and recommendations related to SPC screening. Materials and Methods A nationwide survey was conducted with a representative sample of 496 Korean oncologists. A questionnaire based on the findings from our previous qualitative study was administered. Results More than three-fourths of oncologists (76.3%), who participated in the study, had experience with SPC patients. Over half of them (51.9%) stated that it was an embarrassing experience. While the current management practice for SPC varies, most oncologists (80.2%) agreed on the necessity in proactively providing information on SPC screening. A short consultation time (52.3%), lack of guidelines and evidence on SPC screening (47.7%), and patients’ lack of knowledge about SPCs (45.1%) or SPC screening (41.4%) were most frequently reported as barriers to providing appropriate care for managing SPC. Oncologists recommended the development of specific screening programs or guidelines in accordance to the type of primary cancer (65.9%), the development of an internal system for SPC screening within the hospital (59.7%) or systematic connection with the national cancer screening program (44.3%), and education of oncologists (41.4%) as well as patients (48.9%) regarding SPC screening. Conclusion Many oncologists reported the occurrence of SPC as an embarrassing experience. Given the variations in current practice and the lack of consensus, further studies are warranted to develop the optimal clinical strategy to provide SPC screening for cancer survivors.

Citations

Citations to this article as recorded by

Cardiovascular risk and undertreatment of dyslipidemia in lung cancer survivors: A nationwide population-based study
In Young Cho, Kyungdo Han, Dong Wook Shin, Sang Hyun Park, Dong Woog Yoon, Sujeong Shin, Su-Min Jeong, Jong Ho Cho
Current Problems in Cancer.2021; 45(1): 100615. CrossRef
Developing an instrument to assess cancer patient preparedness for transition to survivorship care in Korea
Jung‐won Lim
Asian Social Work and Policy Review.2020; 14(3): 172. CrossRef
Second Primary Cancer after Treating Gastrointestinal Cancer
Jeong Youp Park
The Korean Journal of Gastroenterology.2019; 74(4): 193. CrossRef
A national survey of lung cancer specialists’ views on low-dose CT screening for lung cancer in Korea
Dong Wook Shin, Sohyun Chun, Young Il Kim, Seung Joon Kim, Jung Soo Kim, SeMin Chong, Young Sik Park, Sang-Yun Song, Jin Han Lee, Hee Kyung Ahn, Eun Young Kim, Sei Hoon Yang, Myoung Kyu Lee, Deog Gon Cho, Tae Won Jang, Ji Woong Son, Jeong-Seon Ryu, Moon-J
PLOS ONE.2018; 13(2): e0192626. CrossRef
The Dyadic Effects of Family Cohesion and Communication on Health-Related Quality of Life: The Moderating Role of Sex
Jung-won Lim, En-jung Shon
Cancer Nursing.2018; 41(2): 156. CrossRef
Physicians’ attitudes towards the media and peer-review selection of the ‘best cancer doctor’: comparison of two different selection methods
Dong Wook Shin, Juhee Cho, Hyung Kook Yang, So Young Kim, Soohyeon Lee, Eun Joo Nam, Joo Seop Chung, Jeong-Soo Im, Keeho Park, Jong Hyock Park
BMJ Open.2018; 8(5): e019067. CrossRef

10,238 View
91 Download
5 Web of Science
6 Crossref

Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey: Dong Wook Shin, Juhee Cho, Hyung Kook Yang, So Young Kim, Su Hyun Lee, Beomseok Suh, Hee-Young Shin, Hyun Joo Lee, Dae Ghon Kim, Jong Hyock Park; Cancer Res Treat. 2015;47(4):591-599. Published online January 5, 2015; DOI: https://doi.org/10.4143/crt.2014.086

Abstract PDF PubReader ePub

Purpose
In response to the challenges and difficulties imposed by rare cancers, multi-stakeholder initiatives dedicated to improving rare cancer care was launched, and several recommendations were made by professional societies. However, these primarily reflect the view of the advocates and supporters, and may not represent the views of the “average” clinician or researcher. In this study, we sought to investigate perceived difficulties with regard to rare cancer care and potential solutions endorsed by oncologists.
Materials and Methods
A representative sample of 420 oncologists recruited in 13 cancer centers participated in a nationwide survey.
Results
Oncologists faced various difficulties in treatment of patients with rare cancers, including the lack of clinical practice guidelines (65.7%) and personal experience (65.2%), lack of approved treatment options (39.8%), and reimbursement issues (44.5%). They were generally supportive of recent recommendations by multi-stakeholder initiatives as well as professional societies for development of clear clinical practice guidelines (66.0%), flexible reimbursement guidelines (52.9%), and a national rare cancer registry (47.4%). However, there was only moderate endorsement for referrals to high-volume centers (35.5%) and encouragement of off-label treatments (21.0%).
Conclusion
Insights into the general attitudes of oncologists gained through our nationwide survey of representative samples would be helpful in development of clinical practices and public health policies in rare cancer treatment and research.

Citations

Citations to this article as recorded by

Choreographed expansion of services results in decreased patient burden without compromise of outcomes: An assessment of the Ontario experience
Kathryn Rzadki, Wafa Baqri, Olga Yermakhanova, Steven Habbous, Sunit Das
Neuro-Oncology Practice.2024; 11(2): 178. CrossRef
Primary Small Cell Carcinoma of the Kidney: Disease Characteristics and Treatment Outcomes
Thomas F. Monaghan, Kyle P. Michelson, Nicholas R. Suss, Christina W. Agudelo, Syed N. Rahman, Dennis J. Robins, Viktor X. Flores, Brian K. McNeil, Jeffrey P. Weiss, Andrew G. Winer
Medicines.2021; 8(1): 6. CrossRef
Rare cancers in India: A road less travelled
HS Darling, Sameer Rastogi
Indian Journal of Cancer.2020; 57(2): 139. CrossRef
Cancer Patients’ Utilization of Tertiary Hospitals in Seoul Before and After the Benefit Expansion Policy
Sanghyun Cho, Youngs Chang, Yoon Kim
Journal of Preventive Medicine and Public Health.2019; 52(1): 41. CrossRef
Physicians’ attitudes towards the media and peer-review selection of the ‘best cancer doctor’: comparison of two different selection methods
Dong Wook Shin, Juhee Cho, Hyung Kook Yang, So Young Kim, Soohyeon Lee, Eun Joo Nam, Joo Seop Chung, Jeong-Soo Im, Keeho Park, Jong Hyock Park
BMJ Open.2018; 8(5): e019067. CrossRef
Rare cancers—Rarity as a cost and value argument
J.-Matthias Graf von der Schulenburg, Frédéric Pauer
Journal of Cancer Policy.2017; 11: 54. CrossRef
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
Gemma Gatta, Riccardo Capocaccia, Laura Botta, Sandra Mallone, Roberta De Angelis, Eva Ardanaz, Harry Comber, Nadya Dimitrova, Maarit K Leinonen, Sabine Siesling, Jan M van der Zwan, Liesbet Van Eycken, Otto Visser, Maja P Žakelj, Lesley A Anderson, Franc
The Lancet Oncology.2017; 18(8): 1022. CrossRef

11,055 View
97 Download
5 Web of Science
7 Crossref

First
Prev
Page of 1
Next
Last

Search